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ABSTRACT
Indomethacln R educes Splenic Red Pulp M acrophage Populations in Fem ale New Zealand
W hite R abbits, 
by
T hane S . Thurmond
In an  effort to elucidate the  m echanism  by which indom ethacln (IN) a ttenuates  
the  stim ulatory effect of estradiol (E2) on  rabbit sp lenic red pulp m acrophages (RPM), 
thirty-nine fem ale  New Z ealand  W hite rabbits w ere divided Into 10 groups: ovarlecto- 
mlzed (OVX), OVX/IN at 0.1 and S.O mg/kg body weight (bw)/day; sham  OVX (SOVX), 
SOVX/IN a t 0.1 and  5 .0  mg/kg bw/day; OVX/25 mg E2, OVX/25 mg E2/IN a t 0.1 and 5.0 
mg/kg bw/day; intact Control. Quantitative changes In RPM population In resp o n se  to 
the  treatm ents w ere m easured  using a  0  to 4  histologic grading sca le . Estradiol 
treatm ent resulted In increased RPM g rade  when com pared to  the  OVX non-E2  groups. 
Indomethacln addition d ecreased  m ean RPM grade In the  SOVX/IN 5.0 group w hen 
com pared to  its E2 control group. Indomethacln administration had no significant effect 
on levels of PG E 2  in the  spleen, blood o r urine (p>.05). Hem atocrits w ere reduced In 
both OVX and OVX/E2  groups and this decrease  w as exacerbated by the high IN dose. The 
resu lts from this study su g g est that the  effect of IN on E2-lnduced RPM activation m ay b e  
m ediated through a  non-prostaglandin pathway. The observed hem atocrit c h a n g es  are 
possibly the result of direct action of IN and E2  on erythrocytes.
To further investigate w hether a  direct Interaction of IN and  E2 with rabbit 
erythrocytes m ay be responsible for the  d e c re a se s  In hem atocrit observed  In vivo, an  In 
vitro study w as conducted to determ ine the  effect of th ese  d rugs on erythrocyte fragility 
characteristics. Two ml aliquots of treated  New Zealand W hite rabbit whole blood w ere 
a ssa y e d  a s ; Control, IN (9.6 pg/ml), E2 (500 pg/ml) and IN plus E2, for c h a n g es  In 
erythrocyte fragility. O sm otic (OF) and  m echanical (MF) fragility w ere evaluated  
under approxim ate physiological conditions by m easurem ent of hemoglobin re le a se  a t 
545 nm. Blood sam ples a t 39.5°C w ere a ssa y e d  Immediately after drug addition 
(Initial) and again  4 hours after Incubation (final). Eight rep lica tes of e a c h  experim ent 
w ere run. R esults of th e  O F a ssa y s  show ed a  significant Increase (p<.05) in m ean 50% 
hem olysis point betw een  IN (final) and IN plus E2 (final) w hen com pared to  their m ean 
initial values and to  the m ean final Control value. T he OF hem olysis dispersion w as 
Increased by IN and IN plus E2 treatm ent w hen final values w ere com pared  to  Initial 
values. T he m ean  final va lues for MF Increased with IN, E2 and  IN plus E2  treatm ent 
v e rsu s  the m ean  final Control value (p<.05). While the  Increase In MF from IN w as 
g rea ter than  th a t from E2l the  MF from the  combination (IN plus E2) w as not g rea ter 
than  from IN alone  (p>,05). T he IN-lnduced Increases in both O F and  MF indicate a  
difference in d eg ree  of Interaction with the  erythrocyte from th a t of E2, which only 
affected MF an d  w hose effect w as not additive o r synergistic with tha t of IN.
Ml
T he In vitro experim ental resu lts dem onstra te  tha t th e  Increased  fragility 
produced by IN and E2  on rabbit erythrocytes m ay account for the  observed  In vivo 
reduction In hem atocrit Increased  erythrocyte fragility would a lso  lead to  their 
accelerated  clearance  from the  circulation by splenic RPM and su b seq u en t Increases in 
activity of th e se  m acrophages. This elevation In splenic RPM population may a lso  be 
enhanced  by direct E2  stimulation of m acrophage proliferation.
Iv
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C hapter 1 
INTRODUCTION
Previous R esearch  
C oogan et al. (1981) found that E2 , adm inistered over a  period of 10 to  12
m onths, p roduced  multlcentrlc, glycogen*rich, reticuloendothelial tum ors in the  sp leen  
and renal m edulla of sexually m ature, fem ale, New Zealand W hite (NZW) rabbits. 
S ubsequen t work dem onstrated  that similar changes in th e  splenic reticuloendothelial 
system  could be induced in a s  little a s  th ree  w eeks by subcu taneous Implantation of 25 
mg su s ta ln ed -re lease  E2 pellets in ovarlectom ized NZW rabbits (Zollars et al., 1985).
T he splenic alterations observed  in this study consisted  of a  splenom egaly characterized 
by reticuloendothelial ceil (REC) hypertrophy and  hyperplasia.
T he exact nature of E2 rs  effect on the splenic reticuloendothelial and  renal
medullary cells Is not known. However, b ecau se  both cell types elaborate targe am ounts 
of the  arachldonate  m etabolite prostaglandin E2  (PGE2 ) (S tenson and Parker,
1980; Lee et al., 1967) a  study w as undertaken In our laboratory to  determ ine if PG E 2
m ay play a  role. This investigation w as designed  to  evaluate PG E2  Involvement by co-
admlnlstratlon of a  prostaglandin pathw ay cyclooxygenase blocker along with E2 . The
cyclooxygenase blocker chosen  w as indomethacln (IN) which Is considered to  be  one of 
th e  m ore poten t of the  non-steroidal antl-lnflam matory d rugs (Insel, 1990). Subcu- 
taneously-lm pianted, su sta lned -re lease  IN pellets a t  d o se  levels of 1.0, 10.0 and  13.0 
mg/kg body weight (bw)/day w ere adm inistered, along with 25  mg susta lned -re lease  E2
pellets, to  sexually m ature, ovarlectom ized, NZW rabbits for a  period of th ree  w eeks. At
1
2th e  end  of the  study  sections of sp leen  from ail groups w ere exam ined histologically and  
th e  two larger IN d o ses  w ere noted to  be  effective In reducing the  extent of the  REC 
hypertrophy and hyperplasia w hen com pared to  the  ovarlectom ized group receiving E2
alone and  th e  group receiving the  low d o se  of IN (data unpublished).
B ased  upon the  resu lts of th is preliminary study, an  /n vivo, 3-w ay cro ssover 
study utilizing 3 trea tm ent regim ens w as undertaken to  further investigate E2  supp le­
m entation-induced splenom egaly and  gain Insight Into IN's actions on  the splenic 
changes. A se t of in vitro experim ents w as a lso  conducted which add ressed  the  effects of 
th e se  two com pounds on the  fragility characteristics of rabbit red blood ceils.
M ononuclear Phaaocvte System
The m ononuclear phagocyte system  consists of prom onocytes, peripheral blood 
m onocytes, m onoblasts in the bone marrow and tissue m acrophages. The m acrophage Is 
th e  primary differentiated cell of this system  and Is found throughout the body in m any 
structural and  functional form s. ThB first u se  of th e  term  "m acrophage" w as by Elie 
Metchnikoff (Karnovsky, 1981) to describe large m ononuclear cells he had observed  in 
tissue sections. Aschoff (1924) included the  m acrophages under th e  broad cell 
classification of the  "reticuloendothelial system " (RES). However, b e cau se  the  RES 
classification contains som e cells of a  non-m acrophage lineage (i.e., endothelial cells, 
fibroblasts and reticular cells) in 1969 the  term m ononuclear phagocyte system  w as 
adopted to  describe  m onocyte-derived phagocytic cells with com m on in vivo functional 
characteristics (van Furth et al., 1972). B ecause  of this change In convention the  term  
m onocytic-m acrophage ra ther than  reticuloendothelial cell will b e  u sed  in this 
publication to  refer to th o se  phagocytic cells, T he monocytic m acrophages of Interest In 
th e se  stud ies a re  those  that reside In the  red pulp of the  rabbit sp leen  (RPM).
Estrogens and the  Immune R esponse
3
General
E strogens a re  naturally occurring horm ones or synthetic steroidal and  non­
steroidal com pounds that exhibit estrogenic  activity. The naturally occurring es trogens 
have  a  basic  cyclopentanoperhydrophenanthrene steroid ring backbone, with an  
unsaturated  A ring, a  C  3 position phenolic hydroxyl group, a  methyl group a t the  C 13 
position and  a  hydroxyl o r ketone group a t the C 17 position. T he natural steroidal 
horm ones consist of estradiol, estrlol, estrone , equllenln and  equtlln; of th e se , estradiol 
(E2 ) h a s  th e  g rea tes t estrogenic activity. Estrogens, along with their functions In
normal system ic growth and  m aturation and developm ent of secondary  se x  characteris­
tics, have also been  shown to have a  regulatory effect on the im m une system  In hum ans 
and In anim als.
EffectS-Of-Estroaen on the  Thvmus. T. B and NK Lymphocytes.
Thymic Effects. Early studies have suggested  that th e  thym us is th e  major target 
organ through which estrogens and se x  horm ones generally exert their 
im m unomodulatory Influence. Sobhon and  Jlrasattham  (1974) observed  that E2
benzoate  adm inistered to  ovarlectom ized rats resulted  in a  significant d e c re a se  in thymic 
weight when com pared to  ovarlectom ized and sham  ovarlectom ized control anim als. In 
th e  sam e  study, the au thors reported th a t ovariectom y In Im m ature rats resulted  in a  
delay  in thymic Involution. In a  m orphom etrlc study of thym uses from ra ts  receiving E2
benzoate  neonatally, L eceta eta l. (1988) observed thymic cortical hypoplastic ch an g es 
characterized by d e c re a se s  In the frequency of large lymphoid cells in that region. 
Screpanti eta !. (1989), In a sse ss in g  the  lymphocyte subpopulatlons involved In the
estrogen-induced  thymic ch an g es, concluded th a t short-term  adm inistration of 170- 
estradlol produced a  d e c rease  in CD4+/CD8+ (DP) su b se ts  and an  Increase In subsets  
CD4+/CD8- (SP), CD4-/CD8- (DN) and , to  a  le s se r  extent, CD4-/CD8+, a s  well a s  an  
increase  In th e  proportion of be ta  TCR+/epsllon CD3+ and  IL-2R+ cells. After long­
term  E2 administration, they  observed a  d e c re a se  in the  effect on  DN/IL-2R+ cells.
Differences in thymic response  have been  observed w hen E2 w as adm inistered
cyclically v e rsu s  chronic adm inistration. In a  study by E rbach and  Bahr (1988) the  
thym uses of ovarlectom ized rats receiving E2 on  a  four-day cycle show ed none of the
atrophic c h a n g es  seen  In th e  ovarlectom ized ra ts  receiving Implanted, constan t re lease  
estradiol pellets.
Effects on T. B and  NK Lvmohocvtes. R esearch  on the  effect of e s trogens on the 
immune system  has show n that in general estrogenic su b s tan ces  d ep ress  T-cell m ediated 
resp o n ses  and  NK cell activity while stimulating th e  B-cell hum oral resp o n se  (Ahmed e t 
a/., 1985). Several researchers  have reported that T cells exposed  to  se x  horm ones In 
culture w ere less  responsive to  the T-cell m itogens concanavalin A (Con A) and phytohe- 
m agglutlnln (PHA) (M endelson et at., 1977; C lem ens et al„ 1979; Wyle and  Kent,
1977). Bellini and his co-investigators (1990) show ed that PHA-stlm ulated hum an 
lym phocytes pretreated  with E2 produce diminished concentrations of cytosolic free
calcium  In com parison to  non-E2 trea ted  control cells. Cleric) et at. (1991) reported
that treatm ent of hum an peripheral blood m onocytes (PBMC) with E2 produced enhanced
immune resp o n se  to sh e ep  red blood cells (SRBC) by Inhibiting CD8+ T lymphocytes 
(suppressor T  cells). Further ev idence of estrogen 's  effect on  sup p resso r T-cells w as  
provided by Ho et at. (1991) who dem onstrated  that patients with estrogen  deficiency
5d u e  to  gonadal dysgenesis  or hypothalamic-pituitary failure had  a  d e c re a sed  CD4(he!per 
T-cell) :CD8 ratio and increased  num bers of CD8+ ceils com pared to  normal control 
g roups.
Work by Erbach and Bahr (1991) in asse ss in g  the  effect of Eg on the  B-cell
humoral re sp o n se  in ovarlectom ized Lewis ra ts  found tha t in order for estradiol humoral 
enhancem en t to occur a n  Intact thym us is required. T hey a lso  observed  that a  constitu­
tive thymic factor found in thymosin fraction 5  exerts a  perm issive influence on  Eg-
induced hum oral immune enhancem ent outside the thymus. Evagelatou and Farrant 
(1994) noted that thym us derived T-cells w ere  n ecessa ry  for Ez action on the
differentiation of B-ceils in cultures of hum an tonsillar lym phocytes. S thoeger et al, 
(1986) dem onstrated  E2  enhanced  pokew eed mitogen (PWM)-induced generation of
plaque forming cells in cultures of hum an peripheral blood m ononuclear. Similar 
results for Eg-potentlatlon of IgG and IgA production by PW M -stimulated B-cells from
multiple sc le ro sis  pa tien ts w ere reported  by Katman et at, (1989).
S eam an  and  Talat (1980) in their work on estrogen-rela ted  im m une system  
changes, reported tha t NK activity w as markedly reduced  In Eg-treated B/W m ice. O ther
authors have  reported similar NK ceil activity ch an g es in Eg-treated TA3 mice of both
se x e s  (Hou and Zheng, 1988) and  In wom en suffering from endom etriosis (Garzetti et 
at., 1993). Screpanti et at. (19B7) reported that the Eg-lnduced NK cell effects w ere
time dependen t, noting that E2  administration in mice for up to 30 d a y s  actually
stim ulated NK cell activity while longer adm inistration d ep re sse d  activity.
Effects of Estrogen on Celts of the M ononuclear Phagocyte System
Estrogenic effects on the  cells that com pose the  m ononuclear phagocyte system  
have been  well docum ented, Fluhmann (1928; 1932) first reported a  d ec reased  
p resence  of vitally stained m acrophages In the endom etrium  of ovarlectom ized rabbits, 
NIcol (1932; 1935) dem onstrated  com parable c h an g es  In the  reticuloendothelial system  
of th e  guinea pig uterine horn endometrium. Both researchers  a lso  dem onstrated  tha t 
normal m acrophage levels could be  restored by administration of natural estrogens. 
Subsequen t work by Nlcol's group and others confirmed that both natural and  synthetic 
es tro g en s produced sim ilar effects (Heller et al., 1957; NIcol and  Bllbey, 1960; NIcol 
eta l., 1966), E strogens a lso  stim ulate resident m ononuclear phagocytes, inducing 
Kupffer cell division In the  liver (Kelly and Dobson, 1971; Boorm an et al., 1980; D ean  
et al.t 1984; D urquet-Perelm ann et al., 1990) and Increasing activity of splenic red 
pulp phagocy tes (N um ano ef al., 1969; W arr and  Sljlvlc, 1973; Zollars e ta l.,  1985).
Although estrogenic stimulatory effects on m ononuclear phagocytes have been 
well established, little Is understood about how th e se  estrogen-related  c h a n g es  are  
Induced, T he likelihood of direct estrogen  Involvement Is given credence  by the 
dem onstration of estrogen  receptors In hum an peripheral m onocytes (W eusten et al., 
1986) and In the  J111 hum an monocytic leukem ia cell line and rat peritoneal 
m acrophages (G ulshan e f al., 1990). Brubaker and  G ay (1994) a lso  reported  specific, 
dose  and time dependen t binding of estradiol to the  surface of avian osteoclasts (a su b se t 
of th e  m onocyte-m acrophage system ). This binding resulted In d ec reased  osteoclast acid 
production and  changes In cell shape. Administration of physiological and  pharm aco­
logical levels of estradiol h as  been  show n to Induce the  production of lnterleukln-1 (IL- 
1) in m urine peritoneal m acrophages (B arahao eta l., 1992; Hu e ta l,, 1988; Flynn, 
1986) and  In LPS-stlm ulated splenic m acrophages from oophorectom lzed ra ts  (Sato e f
al. 1993). Interleukin-1 h a s  been  show n to stim ulate T-lym phocytes to  produce the 
cy tok ines Interleukin-3 (IL-3) and  g ranu locy te /m acrophage colony-stim ulating factor 
(GM-CSF), both of which stim ulate th e  production of peripheral m onocytes (C annlstra 
et al., 1987). Fibroblasts and endothelial cells a re  a lso  sensitive to  IL-1 and  respond 
by producing GM -CSF and  m acrophage colony-stimulating factor (M-CSF) (another 
po ten t stim ulator of m ononuclear phagocyte  production) (Bagby e f a/„ 1986). W hether 
IL-1 Is the m ediator for the  estrogen-induced stim ulation of m acrophage production is 
speculative since recent work h as  dem onstrated  th a t the  production of individual 
m acrophage-related  cytokines may relate to  the level of m aturation and  anatom ic 
location of th e  m acrophage (Friedlander ef at., 1994; Rice ef al., 1981). R ecen t stud ies 
have  a lso  dem onstrated that estrogen  can  directly induce the production of M -CSF by 
uterine epithelial cells In th e  cycling m ouse  (Wood e t al., 1992).
O ther possib le m acrophage-related  actions of e s trogens m ay correlate to  their 
effect on Fc and com plem ent receptor m ediated phagocytosis. Friedm an ef al. (1985) and
Schretber e f  al. (1988) reported that estrogenic com pounds enhanced  the  Fc y receptor-
m ediated c learance  of IgG-coated erythrocytes by splenic m acrophages. Baraflao ef al. 
(1991) show ed  that peritoneal adheren t m ononuclear cells from ovarlectom ized Balb/c 
mice had d e c reased  functionality of m em brane com plem ent C3 t> receptors and reduced
ability to phagocytize Candida albicans, injection of normal levels of estradiol restored 
phagocytic properties to  normal but failed to  resto re  m em brane C^b receptors.
M acrophages produce large quantities of th e  arachldonlc acid-derived 
prostaglandins in response  to  diverse stimuli, but the  am ounts of e ach  type produced 
vary am ong m acrophage populations. Endotoxin, zym osan or m icroorganism -stim ulated 
peritoneal m acrophages produce large am ounts of PG E2 , PGI2  and throm boxane A2 .
Peripheral blood m onocytes in contrast, produce only small am ounts of PGE2 and  PGI2 ,
but large am ounts of throm boxane (Tripp e f a/., 1986). The prostaglandins produced by 
m acrophages not only have a n  effect on vascular permeability but a lso  on  the  
m acrophages them selves. Prostaglandin E2, for exam ple, Is one  of th e  m ost potent
inhibitors of Interferon y-lnduced m acrophage activation (Snyder ef a/., 1982; Taffet 
and Russell, 1981). T he effect of estrogens on m acrophage prostaglandin production and  
consequen t activation has been  add ressed  by several Investigators. Work by Stratton ef 
a/. (1986) show ed that peripheral m onocytes from norm al m enstruating w om en 
produced lower levels of PGE2 and TxB2 and  had higher levels of phagocytic activity w hen
serum  estro g en  levels w ere elevated . Mlyagl e f  al. (1993) reported sim ilar resu lts 
using peripheral m onocytes exposed  to  LPS and E2 In vitro. In their study, however,
they  reported that while the  low do se  of E2 (0.4 ng/ml) d ep ressed  PG E2 production, high
levels (20 ng/ml) resulted  in increased  PG E2 production. Leslie and  P u b ey  (1994)
also  noted that LPS stimulation of hum an peripheral m onocytes Isolated during the  luteal 
p hase  of the  m enstrual cycle had enhanced  prostaglandin production w hen com pared with 
LPS-treated m onocytes Isolated during the  early follicular phase .
T he N on-steroidal Anti-Inflamm atory Drugs
General
T he non-steroidal antl-lnflammatory drugs (NSAIDs) have  a s  a  com m on 
property th e  ability to  Inhibit the  production of the  Inflammatory prostaglandins. The 
salicylate-containing NSAIDs have been  used  for centuries In m any cultures to  trea t a  
variety of inflammatory conditions including th e  arthritldes. N ew er non-salicylate 
NSAIDs that, in som e Instances, proved to  be m ore effective In the  treatm ent of arthritis
than the salicylates and had few er side effects, began  to  be developed In the  late 1960's 
and  early 1S70's. The first of th ese  new NSAIDs w ere Indomethacln and  phenylbutazone. 
Indomethacln w as developed by chem ists a t Merck, S harpe  and Dohm e based  upon the 
hypothesis th a t th e  basic indole structure Is similar to  that of serotonin, thought to be  a  
m ajor m ediator of Inflammation. Phenylbutazone, a  pyrazolone derivative, w as crea ted  
a s  result of th e  efforts of resea rch ers  a t Gelgy in B asel, Switzerland. S ince the 
developm ent of th ese  NSAIDs hundreds m ore have been  tested  for their efficacy In the 
alleviation of th e  pain and Inflammation of the rheum atic d iseases; of th ese  drugs, som e 
30 have been  found effective In the treatm ent of th ese  conditions.
M odes of a c tion In Inflammation and the  Immune, response.
O ne of th e  primary routes by which NSAIDs produce their effects Is by Inhibition 
of the  cyclooxygenase com ponent of the prostaglandin synthesis pathway, Blockade of 
this pathway h a s  been  found to play a  role In the NSAID modulation of the  immune 
response  on several levels although som e observed effects have  been  contradictory 
(Cortet and Duquesnoy, 1991). M artinez and  Colem an (1989) dem onstrated  th a t the 
p resen ce  of Indom ethacln, plroxicam, fbuprofen or aspirin during the  first 24  hours of 
culture of PW M -stlmulated (T and  B cell mitogen) hum an peripheral m ononuclear cells 
resulted in a  m arked d ecrease  in polyclonal IgG synthesis. T hey noted that the  deg ree  of 
IgG production Inhibition w as related to th e  relative abilities of th e  NSAIDs to  inhibit 
cyclooxygenase, Skoidstam  ef a/. (1982a; 1982b) have  observed  that Indomethacln 
blockade of PGE2  augm ents Con A-lnduced Im m unosuppression in patients with rheum a­
toid arthritis, while o thers have  reported a n  indom ethacln-lnduced dep ression  of the 
Im m unosuppressive response  in mice In which an  autoim m une s ta te  had b een  crea ted  
(Nlcklln and  S hand , 1982). Badger eta l. (1982) reported  th a t indom ethacln augm ented
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the C on A produced suppression  of antibody synthesis to sh e ep  red blood cells in Balb/C 
mice, although they  expressed  doubt concerning th e  Involvement of prostaglandins in 
this response .
While cyclooxygenase blockade Is the  primary m echanism  of NSAID action, 
several drugs within this c lass  have b een  shown to ac t via o ther sites and  pathw ays to 
su p p ress  the  Inflammatory p rocess (Rainsford, 1993). B ecause, a s  a  c lass , NSAIDs a re  
planar, anionic com pounds th a t partition Into lipid environm ents such  a s  th e  cell 
m em brane bilayer, it is not surprising that they have been  found to Inhibit m any 
m em brane-associated p rocesses. Indomethacln and the  fenam ates a re  unique am ong 
NSAIDs in their ability to  block phospholtpase A2  (PLA2) in polym orphonuclear
leukocytes (PMN) and  In Inflamed tissue, thereby  Inhibiting th e  production of all 
prostaglandins, th rom boxanes and leukotrlenes (Shakir eta l., 1985; F ranson  eta l., 
1980; J e s s e  and Franson, 1979). T he m echanism  of this NSAID blockade Is felt to  be 
related to their ability to  antagonize the  action of Ca+2, which se rv e s  a s  a  cofactor for 
PLA2 (Northover, 1977). T he fenam ates have a lso  been  found to  act directly at
prostaglandin recep tors, inhibiting th e  binding of prostag landins (R ees e f al. 1988). 
Indom ethacln, plroxicam, ibuprofen (at m icromolar concentrations) an d  aspirin  (at 
mlllimolar concentrations) inhibit th e  fM et-Leu-Phe (FM LP)-lnduced agg rega tion  of 
PMNs by a  non-prostaglandin m ediated  path (Abram son et al. 1984; 1985). Further 
work by Abram son and his group dem onstrated  th a t the  neutrophil FMLP aggregation 
Inhibition resulted  from uncoupling of postreceptor ligand signaling due to  the  ability of 
the  NSAIDs to  induce ch an g es in m em brane fluidity (Abram son ef al., 1990) Indo­
m ethacln and  plroxicam w ere also found to  Inhibit the  production of superoxide anions 
by a  cell-free m em brane preparation of NADPH oxidase (Minta and Williams, 1985);
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su b seq u en t work by Y uda e t al. (1991) show ed that th is effect w a s  attributable to  direct 
blockage of tills enzym e by the  NSAIDs.
NSAID Effect on M ononuclear Phagocytes.
As previously m entioned, the  m ononuclear phagocytes have the potential to 
produce large quantities of arachldonlc acid m etabolites, one  of which, PG E2, a c ts  to
supp ress  further m acrophage activation. Blockade of PGE2  production by th e  NSAIDs
ab roga tes  this Inhibitory effect allowing continued m acrophage activation. Although 
blockade of th e  PGE2 pathway is considered the primary m echanism  of m acrophage inacti­
vation, several au thors have dem onstrated that NSAID administration can  have a n  effect 
on their activity levels without directly affecting prostaglandin production. R ice ef al. 
(1981) in their Investigations on liver p lasm a m em branes of Sprague-D aw ley rats 
show ed  that Indom ethacln adm inistered In vivo directly reduced th e  binding affinity of 
PG E 2 without having an  effect on PG E2 levels, Razin ef al. (1982) dem onstrated  that In
vitro administration of indomethacln to  m ouse peritoneal m acrophages produced a  
significant d e c re a se  In m em brane binding of IgG-coated sh eep  erythrocytes and a  
significant Increase  In m em brane binding of cationlzed ferritin. Indom ethacln adm inis­
tration In Wfro h a s  a lso  been  shown to stabilize m ouse  peritoneal m acrophage lysosom al 
hydrolases In resp o n se  to challenge by C -m ucopolysaccharlde peptidoglycan (Finlay ef 
al., 1975). This effect of indomethacln may be m ediated through its antagonism  of Ca+2, 
which has been  shown to be involved in the  tysosom e fusion p ro cess  in neutrophils 
(Jaconl ef al., 1990) and In the  secretion of lysosom al enzym es by hum an neutrophils 
induced by FMLP and  C 5a (Shaw  etal., 1982).
Rationale
While well docum ented, the m echanism  or m echanism s of e s tro g en 's  stimulatory 
effect on the  monocyte m acrophage system  Is not understood. Q uestions rem ain about 
w hether the  effect Is related  to  a  direct or indirect horm onal interaction with this 
system , o r w hether it m ay be  due to  a  combination of factors. T he p resen ce  of estradiol 
receptors In m onocytes and  o ther cells of this system  m ake direct estrogen  stimulation a  
possibility. As noted earlier, e s trogens also  have o ther effects on the  Immune system  
that m ay indirectly affect monocytic m acrophages. This question is especially applicable 
to splenic monocytic m acrophages since the  splanchnic organs have been  show n to  be an  
important s ite  of first p a s sa g e  uptake of the  e s tro g en s  (Collins et at., 1970). Another 
factor to consider is the  effect of the  es trogens on the  circulatory flow characteristics of 
erythrocytes. Increased  erythrocyte m em brane rigidity h a s  been  reported  during 
pregnancy  (Heilmann, 1986) and In oral contraceptive u se rs  (Hellmann et at., 1981). 
C hanges In the  ability of erythrocytes to p a s s  through the  sp leen  a s  a  result of changes In 
their m em brane deformabilitly would lead to a n  Increase  In splenic red pulp m acrophage 
erythrophagocytic activity. To date  no studies have been  conducted that relate th ese  
changes In erythrocyte deformability to  ch an g es  in m acrophage erythrophagocytosis.
The relevance of a  physiological estrogen  milieu to the  normal function of th e se  cells a lso  
has not been  Investigated. D oes a  m arked decrease  in endogenous estrogen  levels lead to a  
dec rease  In both m acrophage num ber and function?
Indom ethacln 's m echanism  of blockade of the  estradiol-induced splenic m acro­
phag e  hyperplasia m ay represen t a  clinically Important function for this NSAID. The 
primary action of the c la ss  of anti-inflammatory a g e n ts  rep resen ted  by indom ethacln Is 
blockage of the  cyclooxygenase pathway of prostaglandin production. In the  c a se  of 
monocytic m acrophages, Inhibition of prostaglandin production by th ese  cells results In
13
increased  rather than  d e c reased  activity. Indom ethacin 's effect on  the splenic red pulp 
m acrophages m ay be  m ediated by a  non-prostaglandin m echanism , indom ethacin h as  
also  been  show n to have an  effect on hematologic param eters. Mlzushima and Sakai 
(1969) show ed that In vitro incubation of w ashed  erythrocytes with indom ethacln 
resulted  in ch an g es  in their fragility characteristics while Razln e f a/. (1981) repo rted  
that treatm ent of m ice with indom ethacin resulted  In a  significant d e c re a se  In hem ato­
crit. As with estrogen, ch an g es In erythrocyte m em brane characteristics induced by 
indomethacin could lead to  Increased levels of splenic erythrophagocytosls and  su b se ­
quent hem atocrit d ec reases . The question also  a rises  w hether coadministration of the  
two drugs m ay produce an  Interactive effect resulting In an  exacerbation or diminution 
of the  erythrocyte changes occurring a s  a  result of the  p resence  of either drug alone.
Hypotheses
T he p resen t in vivo and In vitro stud ies w ere conducted to investigate the  following 
hypotheses:
• Indom ethacin 's inhibition of estradiol-induced m acrophage stim ulation is
m ediated by a  dose-related  non-prostaglandln m echanism .
• Ovariectomy alone produces a  d ec rease  in the  num ber of red pulp m acrophages
but do es  not have an  effect on their phagocytic capabilities.
• T he stim ulatory action of estradiol on the  red  pulp m acrophages is further
enhanced  by Its direct dam aging effect on erythrocyte m em branes 
resulting In Increased erythrophagocytosls. Indom ethacin a lso  
contributes to  Increased erythrocyte removal by producing c h a n g es  in 
m em brane fragility.
C hapter 2 
MATERIALS AND METHODS
In vivo NZW Rabbit Study
Drugs and Analytical R eagents.
Three-w eek constan t-dose-re lease  IN and  E2  pellets w ere obtained from
Innovative R esearch  (Toledo, OH). Tritium-labeled PG E 2
( [5 ,6 ,8 ,1 1 ,1 2 ,1 4 ,1 5-3H (N )]-PQ E 2) for determ ining PG E 2  recovery  a fte r  tissu e
extraction w as obtained from the New England Nuclear division of Dupont (Wilmington, 
DE). Indom ethacin standard  for determ ination of serum  Indomethacln levels w as  
obtained from Sigm a Chem ical (St. Louis, MO, C at #  I 7378). A nesthetics u sed  were; 
K e ta s e P  (ketam lne hydrochloride) (Bristol Laboratories V eterinary P roducts, 
Syracuse , NY), Rompun® (xylazine) (Mobay Corp., Shaw nee, KS) and  pentobarbital 
sodium  (Fort D odge Laboratories, Fort Dodge, IA)
Animals.
Animals for this study  w ere sexually m ature (m ean weight 3 .45 kg ± 0.23), 
specific-pathogen-free (SPF), fem ale New Zealand W hite (NZW) rabbits obtained from 
Myrtle's Rabbitry (Franklin, TN). T he experim ental protocol and  housing and  care  of 
the  rabbits w ere approved by the E ast T en n essee  S ta te  University Com m ittee on  Animal 
C are  (Project ft 880401) following the  National Institutes of Health and  United S ta te s  
D epartm ent of Agriculture guidelines.
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Experim ental Design.
Thirty-nine rabbits w ere randomly assigned  to  9  trea tm ent groups of 4  anim ats 
each  and  a  tenth control group (nontreated, Intact Control) of 3  anim als. T he treatm ent 
groups w ere; 1.) O varlectom lzed (OVX) Control, 2.) OVX plus IN a t 0.1 mg/kg bw/day,
3.) OVX plus IN a t 5.0 mg/kg bw/day, 4.) Sham  OVX (SOVX) Control, 5.) SOVX plus IN a t
0.1 mg/kg bw/day, 6.) SOVX plus IN a t 5 .0  mg/kg bw/day, 7.) OVX plus 25.0 mg E2, 8.)
OVX p lus 25.0 mg E2  plus 0.1 mg/kg bw/day IN and  9.) OVX plus 25.0 mg E2  plus 5.0
mg/kg bw/day IN. T he maximum IN dose  used  In this study w as chosen  to  reduce the 
possibility of overt toxicity observed In som e anim als a t the higher d o s e s  used  in a  
previous study.
On the Initial day of study body weights and hem atocrits w ere obtained and all OVX 
treatm ent group anim als w ere placed under general an esth esia  (35.0 mg/kg body weight 
K etaset®  plus 7 .0  mg/kg body weight Rompun® Intramuscular, followed by -  1.0 ml 
pentobarbital sodium  Intravascular), ovarlectom lzed and  Implanted subcu taneously  with 
3  w eek  constan t-dose-re lease  pellets containing either IN or £ 2 , o r both pellet types.
The ovaries of the  SOVX groups w ere manipulated and  replaced a t the  tim e of drug 
Implantation under general anesthesia . A schem atic diagram  of the  experim ental 
protocol Is shown on page  16.
Necroosv.
At the  end of the  21-day study period body weights and hem atocrits w ere again  
obtained. All anim als w ere then  euthanized using a n  overdose of pentobarbital sodium  
and necropsled. At necropsy spleen weights w ere obtained, g ro ss  pathologic changes 
w ere noted and sam ples of blood, urine, sp leen  and bone w ere taken  for further analyses.
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In Vh/o Rabbit Experim ental Protocol
Prestudy:
Poststudy:
Randomization 
Body weights 
Blood sm ears 
H em atocrits
Body weights 
Blood sm ears
Day 0 A, Surgery
B. Drug adm inistration
H em atocrits
t
(Day 211 
N ecropsy
Splenic histopathologic grading 
• RPM, hem osiderin, bone 
m arro w
Gross:
A. O rgan weights
- sp leen , u terus
B. Histology
- sp leen , bone  marrow
Biochemical analyses;
A. Indomethactn
- urine, blood
B. Prostaglandins
• urine, sp leen , blood
C. Estradiol
• se rum
S ta tis tics :
A. One-way ANOVA
B. Paired t*Test
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Hlstopalholoav.
S ections of sp leen  w ere fixed In 10% neutral phosphate-buffered formalin 
(NBF), routinely p rocessed  and paraffin em bedded. Sections w ere cut a t  5  pm  and 
stained with hematoxylin and eosln  (H & E) sta ins and  P russian  blue iron stain. Slides 
w ere evaluated blindly for splenic red pulp changes by two independent evaluators. 
C hanges In red pulp m acrophage populations w ere graded using a  0  to  4  grading scale, 
with 0 Indicating minimal p resen ce  of m acrophages and  4 Indicating m arked p resen ce  of 
m acrophages. Cytoplasmic hem osiderin levels In red pulp m acrophages (a m easu re  of 
erythrophagocytosls) w ere evaluated  in P russian  blue-stained sp leen  sections using the 
sam e  grading scale, with 0 a s  an  Indicator of minimal cytoplasm ic staining Intensity and 
4 indicating a  high cytoplasm ic staining Intensity.
Sections of rib bone for marrow evaluation w ere taken  from the  costal-chondral 
region, fixed In NBF and decalcified in a  mixture of 40%  formic acid and  Amberlite IR - 
120 P  Ion exchange resin (Sigm a Chem ical Co., S t, Louis, MO) for a t least 24  hours. 
Following decalcification, the  specim ens w ere routinely p rocessed  for histology and 
stained with H & E stains. Bone marrow evaluations w ere b ased  upon observed changes 
in overall cellularlty, ch an g es In m egakaryocyte num bers and  ch an g es  In num bers of 
myelocyte and  erythrocyte precursors. O bserved changes w ere g raded  from 0 to  4, with 
0  Indicating minimal cell num bers and  4 indicating m arked cell num bers.
H em atocrits.
M icrohematocrits w ere determ ined prior to  th e  beginning of the  study an d  a t 21- 
days using the  procedure of Strum ia et al. (1954). Blood w as draw n from a n  Incision In 
the  m arginal e a r vein of the  rabbit Into heparlnlzed, 75 mm mirocapillary tubes . The 
tu b es  w ere spun for 2  m inutes In a  IEC MB M icrohematocrit centrifuge (Damon/I EC
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Division, N eedham  Heights, MA) and % hem atocrit read  using a  Lancer* Spiracrlt® 
m icrohematocrit reader (Lancer, St. Louis, MO). Each sam ple w as run in duplicate and 
the  results averaged .
Biochemical Analyses.
Estradiol A ssays. Two ml aliquots of rabbit whole blood w ere collected in serum  
separation  tu b es  (Becton-Dlcktnsen, Rutherford, NJ) a t necropsy  and  the  serum  
transferred  to  cryogenic sto rage  vials (Nalge Co., R ochester, NY) which w ere kept 
frozen a t -8 0 'C  until assay ed .
A ssay  for E2 serum  levels w as done using an  acetylcholinesterase im m unoassay
system  obtained from C aym an Chem ical (Ann Arbor, MI)(ACE™EIA kits (Cat. # 
582251)). All reag en ts  w ere provided in the  kit o r p repared  following Instructions in 
th e  a ssa y  kit m anual, Purification of serum  sam ples prior to  a s sa y  w as accom plished 
using a  liquid-liquid extraction procedure a s  follows; 1. 2  ml of deionlzed-dlstllled H2 O
and  10 ml of diethyl e ther w ere added  to  20  ml tes t tubes containing 500 pi of serum , 2. 
te s t  tubes  w ere then vortexed thoroughly and allowed to  stand  for 5  m inutes, after which 
tim e they w ere centrifuged for 10 m inutes a t 2000 x g., 3. the  organic layer w as 
transferred to  a  clean 10 mt te s t tube and the solvent evaporated  under a  s tream  of N2 ,
4 . th e  dried extract w as then  dissolved In 500 pi of EIA buffer. A standard  curve w as 
genera ted  using duplicate 50 pi aliquots of eight different concentrations of th e  estradiol 
standard  provided (range - 7 .8  pg/ml to  1000 pg/ml). Each sam ple w as run a s  50 pi 
aliquots in duplicate a t two different dilutions (1:5 and 1:10). Sam ples and  s tandards  
w ere added  to  96 well EIA plates prepared a s  pe r a s sa y  kit m anual Instructions.
Additional wells w ere used  to  determ ine blank va lues  (B), total activity (TA), non­
specific binding (NSB) and  maximum binding (B0). Estradiol acety lcho linesterase
tracer (50 pi) w as added  to  each  well (except for the  TA and  B wells). T he estradiol 
antiserum  (50 pi) w as then added  to  each  well (except for TA, NSB and B wells),
The p lates w ere then covered with aluminum foil, incubated for o n e  hour on a  
Vortex G enie 2 TM shaker (Fisher Scientific, Pittsburgh, PA) and  developed using 200 pi 
of Ellm an's R eagen t (acetylcholinesterase substra te) per well (except for th e  TA wells 
which received 5 pi of tracer). Upon completion of developm ent the  plates w ere read  a t 
412 nm on a  Vmax kinetic microplate read er (Molecular Devices, Menlo Park, CA) and  
the  results analyzed using SOFTmax® EIA analysis softw are (Molecular Devices, Menlo 
Park, CA). Sam ple E2 concentrations w ere determ ined a s  follows; 1. average  NSB w as
subtracted  from average  B0 to  determ ine corrected B0, 2. th e  average  NSB reading w as
then  subtracted  from the  sam ple or standard  well reading and  divided by the  corrected 
B0 , this figure w as multiplied by 100 to yield %B/B0, 3. a  linear regression  curve for
the  estradiol standards w as then  generated  using concentration a s  the  X variable and 
% B/B0 a s  the  Y variable, unknown sam ple concentrations w ere determ ined by entering
%B/B0 a s  the  Y value to  determ ine the concentration X value.
Prostaglandin A ssays. Sam ples of blood, urine and sp leen  for PG E2 analyses
w ere collected in silicon coated  te s t tu b es  containing IN (25 pg/ml dissolved in ethanol) 
and added  to  phosphate  buffered satlne (PBS). T he urine and  blood sam ples w ere then 
frozen a t -80°C while the  sp leen  sam ples w ere hom ogenized in PBS with 10 second 
bursts of a  Tekmar® Tissumlzer® tissue  hom ogenizer (Tekm ar Com pany, Cincinnati,
OH) and  then  frozen a t -80*C. PGE2 levels w ere determ ined using an  ACE®-EIA a s sa y  kit
(Caym an Chem ical Co., Ann Arbor, Ml, C at#  514011). Urine sam ples w ere a ssay ed
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directly while blood sam ples and sp leen  hom ogenates w ere purified using a  solid p h ase  
extraction procedure a s  follows; 1. a  500 pi sam ple aliquot w as add ed  to a  c lean  te s t tube 
to  which 5000 cpm  of pHJ*PGE2  had  been  added , 2. 2  ml of ethanol w ere then  added  and
th e  tube vortexed, 3. the  sam ples w ere allowed to  stand  for 5  m inutes at 4°C and  then 
centrifuged for 10 m inutes a t 1500 x g, 4. the  supernatan t w as then  poured into a  c lean  
10 ml tube, 8  ml of 0.1 M phosphate  buffer (pH 4) ad d ed  an d  the  tube vortexed, 5. a  
Millipore® C-18 reverse  p h a se  Sep-Pak®  cartridge (W aters A ssocia tes, Milford, MA) 
w as then  activated by rinsing with 5 ml of ethanol followed by 5 ml of distil led- 
delonlzed H2 O, 6. the sam ple w as p assed  through the  cartridge followed by 5 ml of
dlstllled-delonlzed H2 O and 5 ml of HPLC grade  hexane (J. T. Baker Inc., Phililpsburg,
NJ), 7. the  sam ple w as then  eluted with 5 ml of ethyl ac e ta te  containing 1% ethanol, 8. 
the  eluted sam ple w as dried under a  stream  of N2  and resuspended  in 1 ml of EIA buffer
(from a s sa y  kit), 9. 500 pi of the  sam ple w as u sed  for scintillation counting with the  
rem aining 500 pi used  for the EIA analysis.
S am ples for scintillation counting w ere su sp en d ed  in 2 .5  ml of comm ercial 
scintillation cocktail (ScintiVerseTM | ( F isher Scientific, Pittsburgh, PA) and  counted 
for 1 minute on a  Beckm an LS 9800 liquid scintillation coun ter (Beckm an Instrum ents, 
Inc., Irvine, CA). Counting results w ere recorded In counts p e r m inute (cpm) (counting 
efficiency = 33.0% ). A recovery factor (RF) w as calculated  using the following 
fo rm ula ;
PP  = _________ 2 x cpm of sam ple________
3 [H ]- PG E2  added  to sam ple (cpm)
Enzym e Imm unoassay for sam ple PGE2  content w as conducted In the  sam e w ay a s
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for the E2  assay . All sam ples w ere run In duplicate a t two concentrations with the
following exceptions; 1. a ssayed  sam ple concentrations w ere 'undiluted* and ”1:10 
dilution”, 2. PGE2 standard w as added at eight concentrations In a  range of 3.9 pg/ml to
500 pg/ml and 3. plates w ere incubated for 18 hours prior to developm ent. Calcula- 
tlons for %B/B0 and determination of PGE2  In each  sam ple were done a s  previously
shown for E2 determination. Calculation of final PGE2 concentrations w ere done using
the following formulas:
   , * .............................................Value from EIA ( p g / m l )  , ,  t
PG Eg (pg) In extracted sam ple = ----------------— ------ 2-------   - added d [Hl- PG E2 (pg)
PG Ep (pg) In extracted sam ple
Total PGEo In sam ple (pg/ ml) = — ---------:— — -7- . -------------------— - f — r - r -£ r  Volume of sam ple used  for purification (ml)
Indomethacln Assays. Analysis of IN levels in serum  sam ples w as done using a  
spectrofluorometrlc procedure. Sam ples for analysis w ere extracted using a  modifica­
tion of the procedure of Kim ef a l  (1988). The procedure used Is a s  follows; 1. 500 pi 
of serum  (sam ple or spiked standard) w as mixed with 10 ml of ACS grade  methylene 
chloride In a  15 ml capped centrifuge tube and shaken vigorously for 20 minutes before 
being centrifuged a t 2500 rpm for 5 minutes, 2. following centrifugation, the upper 
aqueous layer w as aspirated and the  organic layer w as slowly evaporated to dryness a t 
60°C under a  stream  of N2, 3. the residue remaining after drying w as reconstituted In 3
ml of 0.01 N sodium hydroxide and the tube gently Inverted for 10 minutes, 4. the  tubes 
were then allowed to sit for 20 minutes prior to analysis. Analysis of IN levels w as done 
using a  Turner 430 spectrofluorom eter (excitation 295 nm, em ission 385 nm)
(Turner A ssociates, Palo Alto, CA). A standard curve w as generated using normal SBrum
2 2
spiked with IN. This curve w as linear over a  concentration range  of 250.0 ng/ml to 1.0 
pg /m l (r= .99 ).
Statistical A nalyses.
Statistical ana ly ses of the results of this study w ere done  using the  paired t-Test 
to  com pare pretreatm ent and  21-day resu lts, Intergroup significance w as evaluated 
using a  one-w ay ANOVA with a  Duncan New Multiple R ange post-hoc te s t or a  Kruskal- 
Walils test. An a  level of .05 w as se t  for determining significance. S tatistics w ere done 
using either StatView™  11 (Abacus C oncepts, Inc., Berkeley, CA) o r SuperANOVATM 
(Abacus Concepts, Inc., Berkeley, CA) com puter softw are packages.
In vitro NZW R abbit Ervthrocvte Fragility S tud ies
Drugs and Analytical R eagents.
W ater soluble 17Q-Estradlol (E2) (170-estradlol en capsu la ted  In
2-hydroxypropyl-B cyclodextrln, Sigm a Chem ical C om pany, St. Louis, Mo.) w as 
prepared  In D ulbecco 's P hosphate  Buffered Saline (PBS) (pH = 7.4) (Gibco Laborato­
ries, Grand Island, NY) and  added  to  rabbit whole blood a t a  level of 500 pg/ml. 
Lyophlllzed Indom elhacln sodium  trihydrate (IN) (INDOCIN® I.V., Merck S h arp  & 
Dohme, W est Point, PA) w as dissolved in PB S to a  concentration of 1 mg/ml and added  to 
rabbit whole blood at a  level of 9.6 pg/ml. Stock buffered sodium  chloride for the 
osm otic and m echanical fragility a ssa y s  w as prepared by dissolving 90.0  gm NaCI,
13.65 gm  Na2H P 0 4 and 2.43 gm  NaH^PCVHaO in 1 liter of distilled w ater and  the  pH
adjusted  to  7 .4  with 2N NaOH (chem icals from F isher Scientific, Pittsburgh, PA). 
C ltra te-P hosphate-D ex trose  (CPD) an ticoagu lan t/p reservative  (327.0  mg citric acid, 
2 .55  gm dex trose and  222.0 mg N aH aPO vH aO  In 100 ml of dlstilled/delonlzed w ater •
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chem icals from Fisher Scientific, Pittsburgh, PA) w as added  to  e ach  blood collection 
tube.
Anim als.
T he anim als u sed  for bleeding w ere sexually m ature, fem ale, S P F  NZW rabbits 
obtained from Myrtle’s  Rabbitry (Franklin, TN). T he experim ental protocol and  
housing and ca re  of the rabbits w ere approved by the  E ast T e n n e sse e  S ta te  University 
Com m ittee on Animal C are  (Project ft 940104) following the  National Institutes of 
Health and United S ta te s  Departm ent of Agriculture guidelines.
Drug Co ncentratlon_Selectlon.
The E2  d o se  for the  osmotic and m echanical fragility a ssa y s  w as selected  based
upon the m ean value obtained from the  s e ra  of the  E2 -supplem ented OVX groups in the  In
vivo study which w as approxim ately 500 pg/ml. The IN do se  w as se lec ted  b a sed  upon 
constan t Infusion of a  5  mg/kg bw/day d o se  over a  three*week period and w as calculated 
a s  follows:
1 . Given that the  m ean weight of anim als receiving th e  high d o se  of IN w as
3.49 kg, then  each  anim al received approxim ately 17.44 m g/day 
(5 X 3.49) o r 726 .7  pg/hr which eq u a ls  the Infusion ra te  (IR).
1 .4 4  <t1/a){f)(IR)
2  Average concentration (C ) = ------------- --------------
P v ,<d
W here t i /2  for IN = 2 .4  hr., f (fractional absorption) = 1, IR = 726 .7  pg/hr, V j
(Volume of distribution) = 0 .26  l/kg
FinaLvalu9-0f_C[l-=_9.6-uq/ml-0f blood
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Blood-Collectlon.
Blood w as collected from the  m arginal e a r  veins of 2  fem ale, specific-pathogen- 
free, New Z ealand W hite rabbits (which had received 0.1-0.2 cc of the  
analgesic /tranqu ilizer INNOVAR-VET® (Pltman-M oore, Inc., W ashington C rossing, NJ) 
intramuscularly) using a  vacuum  b leeder (Bellco G lass, Inc., Vineland, NJ). Each 
animal w as bled on a lternate  days. Aliquots of 10 ml w ere bled Into sterile boroslllcate 
tu b es  containing 1.4 ml of CPD. Blood w as m aintained at 3 9 .5 'C  and used  within one 
hour after collection.
Osm otic Fragility Assay,
A ssay  P rocedure. Erythrocyte osm otic fragility w as determ ined using a  
modification of th e  m ethod of Dacia (1954). A 50 pi aliquot of rabbit whole blood a t 
39.5°C (m ean rabbit body tem perature) w as added  to  each  of twelve, 16 X 100 mm, 
boroslllcate culture tu b e s  containing 5  ml of e ither 0 .85, 0 .75, 0 .65, 0 .60 , 0.55,
0,50, 0.45, 0 .40, 0 ,35, 0,30, 0.20 or 0 .10  percent NaCI and to  one  tube  containing 5 
ml of distilled/deionized w ater. T he tu b es  w ere briefly vortexed (Vortex G enie 2™, 
F isher Scientific, Pittsburgh, PA) and  incubated for 3 0  m inutes a t 39.5°C  (ail 
Incubations w ere done in a  Stabil-Therm® Dry Type Bacteriological Incubator (Blue M 
Electric Co., Blue Island, IL)). Following Incubation, th e  tu b es  w ere centrifuged for 5 
m inutes a t 2000 rpm In an  I EC DPR-6000 centrifuge (Intl. Equip. Corp., N eedham  Hts., 
MA). The am ount of solubilized hemoglobin resulting from erythrocyte rupture w as 
m easured  by abso rbance  readings In a  Shim adzu UV160U UV-VIS dual beam  spectro­
photom eter (Shlm adzu Corp., Kyoto Jap an ) a t a  wavelength of 545 nm, using th e  
supernatan t from the 0.85%  NaCI tube a s  the  blank. T he abso rb an ces  obtained w ere then 
plotted on a  curve versus the  NaCI concentrations.
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R esu lts Analysis. A bsorbance results for the  osm otic fragility a s s a y s  w ere 
analyzed using a  mathematical model based  upon an  assum ed  G aussian  distribution for the 
p lasm a m em brane strengths for the erythrocyte population in e ach  a ssay . T he derivation 
of this model Is d iscussed  a t length by Orcutt eta!. (1995) and will not b e  a d d ressed  
here. The abso rbance  (Abs) model u sed  is represented  by the  following equation:
Abs = p3 erfc | x '  ■?—  J
where x  rep resen ts  the  applied osm otic s tre ss  (m easured  a s  NaCI concentration), p1 is 
the  location of the  maximum point for the distribution function (m easured  a s  NaCI 
concentration), p2 Is the  width of that distribution function (m easured  a s  NaCI 
concentration), p3 is a n  experim entally determ ined m easu re  of th e  num ber of eryth­
rocytes p resen t (m easured a s  maximum erythrocyte hem olysis ab so rbance) and  Is 
constan t for a  given sam ple and erfc Is the  complim entary error function.
M echanical Fraqillty A ssav.
Erythrocyte m echanical fragility evaluation w as conducted using a  modification of 
th e  procedure of M cPherson et. al. (1986). Twenty-five pi of rabbit whole blood (In 
triplicate) a t  39.5°C  w as added  to screw -capped , 13 X 100 mm, borosilicate tu b es  
containing 5 ml of 1% NaCI (1:10 dilution of stock sodium  chloride solution). E ach  tube 
(except for spon taneous hem olysis tubes) contained three-3  mm diam eter, soda-llm e 
g lass  b e a d s  (F isher Scientific, Pittsburgh, PA). Following whole blood addition, the 
tubes w ere allowed to stand  for 15 m inutes a t 39 ,5 ’C and then  placed on a  tube  rocker 
(Thermolyne Corp., Dubuque, iA) for 90 m inutes a t  39.5*C. The tu b es  w ere then  
centrifuged for 10 m inutes a t 2000 rpm and the  supernatan ts  read  a t  a  w avelength of 
545 nm to determ ine the  supernatan t hemoglobin optical density  (SOD). T he red blood
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cell pellet remaining In the  tubes w as hem olyzed by adding 20 pi of a  10% solution of 
Nonldet P-40 (Sigm a Chem ical Co., St. Louis, MO) and vortexlng th e  tubes  for 10 
seconds. T he hemolyzed pellet w as then  added  to  the  supernatan t and  this solution w as 
read  a t 545 nm to determ ine the  total optical density (TOD). P e rcen t hem olysis w as 
determ ined by dividing the  SOD by the  TOD and multiplying by 100 (SOD/TOD X 100). 
Hemoglobin re lease  d u e  specifically to m echanical s tre ss  w as determ ined by subtracting 
the  m ean percent hemolysis of the  spon taneous hem olysis tubes (no beads) from the  
percent hem olysis values for the  tubes  containing g lass beads,
Experim ental Protocol.
Experim ental protocols w ere initiated within a n  hour after blood collection. A 2 
ml aliquot of rabbit whole blood w as added  to each  of four sterile boroslllcate tubes 
containing PB S alone, PBS plus 500 pg/ml E2 , PBS plus 9 .66 pg/ml IN (2.7 X 10*5 M)
or 500 pg/ml E2  plus 9 .66  pg/ml IN. Osm otic and m echanical fragility a s sa y s  w ere
done for each  tube a t th e  time of blood addition (I.e., Initial results). Mlcrocaplllary 
tube packed cell volum es (PCV) w ere also  oblalned shortly after the  blood w as add ed  to 
each  tube (using the m ethod of Strum la e l a/. (1954), s e e  pag e  18). All tu b es  w ere then 
Incubated a t 39.5°C for four hours prior to  conducting a  second se t of osm otic and  
m echanical fragility a s s a y s  (I.e., final results) and obtaining post-lncubatlon PC  V s , 
Each experim ent w as repeated  eight tim es using freshly obtained blood. A schem atic 
diagram  of th e  experim ental protocols Is show n In the  flow chart on  p ag e  28.
Statistical A nalyses.
An a  level of .05  w as s e t  for determining significance for all statistical tes ts . 
S tatistics w ere obtained using either StatVlewTM || (Abacus C oncepts, Inc., Berkeley,
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CA) o r SuperANOVATM (Abacus Concepts, Inc., Berkeley, CA) com puter software 
packages.
Osm otic Fragility R esults. M athematically com puted resu lts for p1 and  p2 from 
e ach  experiment w ere averaged  for each  treatm ent and com pared using a  two-way ANOVA 
b a sed  upon the  Independent variables treatm ent and time, Palr-wlse com parisons using 
a  t-Test of least sq u ares  m ean  values w ere done for each  variable w hen th e  ANOVA 
indicated significant trea tm en t variation.
M echanical Fragility R esults. Hemolysis resu lts of the  initial and  final 
m echanical fragility experim ents w ere averaged  and  the  m ean values w ere te s ted  using a  
one-w ay ANOVA based  upon treatm ent. A Tukey-Kramer HSD post-hoc tes t w as done 
w hen the ANOVA indicated significant treatm ent variation.
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Osmotic and Mechanical 
Fragility 
Experimental Protocols
Rabbit blood collected from marginal ear vein into CPD 
anticoagulant/preservative
Experimental design:
1. Control (2 ml whole blood + 208,6 pi PBS)
2. Indomethacin (2 ml whole blood + 30,6 pi of 9.6 pg/ml IN + 250 pi PBS)
3. Estradiol (2 ml whole blood + 250 pi of 500 pg/ml E2 + 30.6 pi PBS)
4. Indomethacin + Estradiol (2ml whole btood + 30.6 pi of 9.6 pg/ml IN +
250 pi of 500 pg/ml E2)
Assays were run at lime of drug addition and 4 hours later, after incubation at 
39.5*C,
Osmotic Fragility Mechanical Fragility
' r
Procedure:
1, 12 tubes/assay containing 0.85 to 0.1% 
NaCI + a  Dl water tube
Procedure:
1 .25  pi blood from each regimen added to
each of 3 tubes containing 3*3 mm 
glass beads, a set of control tubes 
contain no beads
2. 50 pi treated blood added per tube, 
incubated at 39.5*C for 30 minutes
3. Centrifuge for 10 mln. @ 2000 rpm 2. tubes rocked for 1.5 hrs. @ 39.5*C,
centrifuged and supernatant read @ 545 
nm to generate supernatant optical 
density (SOD)
4. Supernatant read @ 545 nm to generate 
an optical density curve for each 
regimBn
3. total optical density (TOD) determined by 
adding Nonidet P*40 to pellet, 
combining with supernatant and reading 
at 545 nm.
4. percent hemolysis = SOD/TOD X 100
5. mean control value subtracted from 
treatment value to determine 
hemolysis due to mechanical fragility
Chapter 3.
RESULTS
In vivo NZW Rabbit Study
Spleen W eights.
M ean w eights of sp leens for the  OVX/E2 /IN 0,1 and  OVX/E2 /IN 5 .0  g roups were
significantly g rea ter than  the  sp leen  w eights for their respective control groups In the 
OVX and  SOVX treatm ent regim ens and for the intact Control group (Figure 1). Mean 
sp leen  weight values for anim als In the  OVX Control and OVX/IN groups w ere not 
significantly different from their respective SOVX control groups, nor w ere  they  
significantly different from th e  m ean value  for the  intact Control group.
Histopathologic Evaluations.
Correlations in grading of histologic changes for the  two evaluators w ere r =
.925 for RPM g rad e  and  r = .985 for hem osiderin staining grade.
Solenlc red duId  m acrophages. T he histologic ap p earan ce  of the red pulp In RPM 
grade 0 sp leens consisted  of num erous well-defined, slightly dilated venous s in u ses  and 
thin splenic cords with few m acrophages. With higher g rade  the  architecture becam e 
increasingly disrupted a s  the  cords becam e thicker and  m acrophages m ore num erous, 
often forming whorled n ests  of cells. T he venous s inuses  in th e se  higher g rad es  becam e 
less  abundant and m ore dilated. G rade 4 sp leens often contained a re a s  of red pulp which 
consisted of sh e e ts  of m acrophages with tittle or no evidence of normal venous sinus 
organization, R epresentative sp leen  sections for the  0 to  4  grading scale  u sed  to  evaluate 
changes in splenic RPM g rades a re  shown In P la tes 1a  - 1e.
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Ovariectom y produced an  overall significant d e c re a se  (p<.05) in num bers of 
splenic cord RPM when comparison w as m ade to the  SOVX and E ^supplem ented
treatm ent regim ens and to  the  Intact Control group. Supplem entation with E2  Increased
the  RPM g rade  over that of the  OVX regim en although not to  a  level which w as slgnlfl- 
cantly g rea ter than  that of the  Intact Control group. T he addition of IN w as effective In 
decreasing the  RPM g rade  In the  SOVX/IN 5.0 group when com pared to its respective 
control In th e  OVX/E2 trea tm ent regim en (OVX/E2/IN 5.0). (Figure 2)
RPM hem osiderin staining Intensity. Evaluation of hem osiderin levels In the 
splenic RPM Indicated a  low level of staining In th e  sp leens of the  OVX E2 -supplem ented
groups with the  m ean g rades of the OVX/E2  Control and  OVX/E2 /IN 0.1 levels being
significantly different from that of the  intact Control group (Figure 3). T he  rem aining 
groups hem osiderin  staining levels w ere not significantly different from their 
corresponding control groups or from that of the intact Control group. An exam ple of a  
hem osiderin g rade  4 sp leen  section is show n In P late 2.
Bone marrow evaluations. No significant differences w ere found am ong any of the  
groups In evaluations of overall bone  marrow cellularlty, num bers of erythrold 
p recursors, myeloid p recu rso rs  o r m egakaryocy tes (p<.05).
H em atocrits
The pretreatm ent m ean hem atocrits for each  group ranged betw een 39%  and 
45% . T he 21 -day m ean values ranged betw een 36%  for the OVX/E2/IN 5 .0  group and
41%  for the  SOVX/C group. Indom ethacin treatm ent a t 5.0 mg/kg bw/day resulted  In a  
significantly reduced 21 -day m ean hem atocrit (p<,05) In th e  OVX group (Figure 4).
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Estradiol supplem entation also  resulted in reduced m ean  21-day hem atocrits and 
addition of IN a t 5.0 mg/kg bw/day exacerbated  the  E2  effect.
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Control
OVX/E2/IN 5.0
OVX/E2/IN 0.1
§*  OVX/E2 Control 
O
5  SOVX/IN 5.0
c  SOVX/IN 0.1 
©
£  SOVX Control 
(0
OVX/IN 5.0
OVX/IN 0.1
OVX Control
0 1 2  3 4
Spleen Weights (gm)
Figure 1. M ean sp leen  weight Intergroup com parisons (±SEM). A -Slgnlflcantly 
different from OVX/IN 0.1 and SOVX/IN 0.1 g roups (p<.05), B-Slgnificantly different 
from OVX/IN 5.0  and  SOVX/IN 5.0  groups (p<.05), C-Slgniflcantly different from 
OVX/E2  Control group (p<,05), D-Significantly different from intact Control group 
(p<.05) (n = 4. excep t for Intact Control w here n = 3).
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Figure 2. Intergroup significance of m ean  splenic RPM grade  (*SEM). A-SIgnlflcantly 
different from OVX/IN 0.1 group (p<.05), B-Signiftcantly different from OVX/IN 5.0 
and  SOVX/IN 5.0  groups (p<.05), C-Signlficantly different from OVX Control group 
(p<.05), D-Slgniflcantly different from intact Control group (p<.05), E-Signlflcantly 
different from OVX/IN 5.0  group (p<.05) (n = 4, except for intact Control group w here 
n = 3).
Plata la  (Top). Photomicrograph of grade 0 rabbit splenic red pulp with well-defined 
venous sinuses (short arrow) and thin splenic cords (long arrow). H & E.( X 160.
Plate tb (Bottom). Grade 1 splenic red pulp, H & E.t X 160
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Plate 1o (Top). Grade 2 splenic red pulp. H & E., X 160 
Plate 1d (Bottom). Grade 3 splenic red pulp. H & E., X 160
3 6
Plate 1e. Grade 4 splenic red pulp, note greater loss of architecture with greatly 
thickened splenic cords and few venous sinuses. H & E., X 160.
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Plate 2. Photomicrograph of hemosiderin laden splenic RPM In a grade 4 spleen (OVX 
Control animal). Prussian blue Iron stain, X 200
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©
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RPM hemosiderin staining Intensity grade
Figure 3. Intergroup com parison of m ean  splenic RPM hem osiderin staining intensity 
g rad e s  (±SEM). (‘ Significantly different from Intact Control group level, p<.05) (n = 
4, except for intact Control group w here n = 3).
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Hematocrit (%)
5030
□  PreHct 
B  PostHct
Figure 4. Com parison of pretreatm ent and  21-day m ean hem atocrits (‘Significantly 
different from pretreatm ent value, p<.05) (n = 4, except for Intact Control group 
w here n = 3).
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Biochemical Analyses.
Serum  estradiol levels. M ean serum  levels of estradiol w ere significantly 
elevated In th e  OVX/E2 -supplem ented groups (Figure 5) w hen com pared to  th e  OVX non­
supplem ented group. T he levels of E2  In the  SOVX groups and  th e  Intact Control group
w ere highly variable and a re  not shown. The c a u se  for this high variability m ay be 
related  to  the  fact tha t although rabbits a re  Induced-ovulators they  do  display a n  estrus 
cycle with m arked ch an g es  In estrogen  levels on a  day-to-day b asis  (Batra and 
KSIIstrand, 1979).
P rostaglandin  E2  levels. Prostaglandin E2  levels w ere not significantly different 
for any  of the  tissu es  analyzed .
Indom ethacln levels. Levels of IN In blood and  urine from the  0.1 and  5 .0  mg/kg 
bw/day groups w ere below the  detectable range of th e  a ssay .
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Figure 5. Intergroup significance for serum  levels of E2  In OVX and OVX/E2 -sim ple­
m ented groups (standard error bars not shown d u e  to  high level of intra-group 
variability). (‘ Significantly different from  respec tive  OVX/E2 *supp lem en ted  control 
g ro u p .)
In vitro NZW Rabbit Erythroevle S tudies
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O sm otic F raa llltv Experim ents.
The resu lts for the  osm otic fragility experim ents a re  show n in Figure 6  
(norm alized initial osm otic fragility curve, Figure 6 ; norm alized final osm otic fragility 
curve, Figure 7). Statistical ana ly ses of the m ean  values for p1 (50% hem olysis 
point) Indicated that there  w as no significant difference betw een th e  p1 va lues for the  4 
treatm ent groups a t the  Initial m easurem ent. A nalyses of the  final results show ed that 
the  m ean  p1 va lues for the  Control and  Eg trea tm ents w ere  significantly different from
th o se  for the  IN and IN plus E2  treatm ents. This significance Indicates a  g rea ter deg ree  of
hem olysis for the  IN and IN plus E2 trea ted  erythrocytes when com pared to Control and
E2  trealed  erythrocytes a t the  sam e NaCI concentration. Com parison betw een Initial and
final m ean  p1 values for each  treatm ent Indicated that a  significant Incease  In osm otic 
fragility for IN and  IN plus E2  trea ted  erythrocytes occurred betw een  th e  initial
m easurem ent and  the final m easurem ent (Figure 8 ).
A nalyses of the p2 (hemolysis dispersion) m ean values Indicated that no 
significant difference am ong th e  trea tm en ts  existed a t the initial m easu rem en t or after 4  
hours. A significant change  did occur for the  p2  values for IN and IN plus E2  treated
erythrocytes betw een the  Initial and  final m easu rem en ts (Figure 9), This finding 
Indicates that a n  Increase In population susceptibility to  osm otic s tre ss  occurred for the  
erythrocytes in th e se  two treatm ents.
M echanical F ragility Experim ents.
The resu lts of the  8  m echanical fragility experim ents a re  show n in Figure 10. 
T here  w as no significant difference In m ean  MF values betw een the  treatm ents a t  the
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Initial m easurem ent. The m ean  levels of hemolysis for the IN, £ 2  and  IN plus E2 -treated
sam p les  a t the  final m easurem ent w ere all g reater than  that of th e  Control a t that time. 
The effect of E2  in the IN plus E2  regim en w as neither additive nor synergistic with the
IN Induced hemolysis. It m ust also be noted that E2  did not have a  diminutions! effect In
the  results from th e  IN plus E2  regim en.
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Figure 6 . Normalized values for osm otic fragility resu lts  a t tim e of drug addition 
(initial resu lts) (m ean of 8  experim ents ± SEM)
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Figure 7. Norm alized va lues for osm otic fragility resu lts  a t  4  hours (final results) 
(m ean of 8  experim ents ± SEM)
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Figure 8 . Com parison of m ean NaCI concentrations (± SEM) a t which 50% hem olysis 
(p1) occurred over tim e for each  trea tm en t regim en ^Significantly different from 
Initial trea tm en t regim en and  final Control value, p<.05) (n = 8 ).
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Figure 9. Com parison of m ean  NaCI concentrations (± SEM) for d ispersion of erythro­
cy te  hem olysis (p2) for e a c h  treatm ent regim en over time f  Significantly different 
from Initial trea tm ent regim en values. p<,05) (n = 8 ).
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Figure 10. Com parison of m ean erythrocyte m echanical fragility hem olysis resu lts 
(± SEM) for e a c h  trea tm ent regim en over tim e fS ignificantly  different from final 
Control value, p<.05) (n «  8 ).
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Packed Cell Volumes
No significant differences w ere observed betw een the m ean  Initial and  final PCVs 
for any o f the  treatm ent regim ens (p>.05), nor w ere any of th e  m ean  final PCVs for th e  
IN, E2  and  IN plus E2  regim ens significantly different from th e  m ean  final Control value
(p>.05). T he IN and IN plus E2 *treated sam ple final mlcrocaplllary tubB packed  cell
colum ns exhibited pooriy defined m argins with Indication of so m e  d eg ree  of hem olysis a t 
the  cell colum n-serum  interface.
C hapter 4  
DISCUSSION
In vivo NZW Rabbit R esults
G ross findings.
Administration of IN and E2 *supplementation had no significant effect on  spleen
weight changes in the OVX or SOVX groups when th ese  com pounds w ere adm inistered 
alone; however, when they w ere adm inistered together (IN plus E2 ) a  significant
Increase In sp leen  weight w as se en . This su g g ests  that a  synergistic Interaction Is 
occurring betw een IN an d  E2 In th ese  groups. The lack of significance in m ean sp leen
weights betw een the low and high d o se  IN plus E2 -supp1em ented groups su g g ests  that the
Interaction Is not d o se  related within this d o sag e  range, The m ain factor In the  Interac­
tion may be  the  constant p resence  of pharm acologic levels of E2  s ince the m ean spleen
weights In the  estrogen-reduced OVX and the  normal physiologic estrogen  SOVX groups 
receiving IN w ere not significantly different from each  other, nor w ere they  different 
from the m ean  weight of the  Intact Control group. Although both IN (Nikcevlch e f a/., 
1986; S eru sh ag o  ef a/., 1987) and  E2  (Crandall e fa / . ,  1980; S asak i a n d  Ito, 1981)
have been  associated  with occurrence of splenic hem atopolesis which could account for 
the  elevated weights, evaluation of the sp leens from the  p resen t study  show ed  minimal 
evidence of splenic hem atopolesis. W hen hem atopolesis w as observed, Its1 occurrence 
did not correlate with Increased sp leen  weight.
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HIstopathQlQQV.
Splenic RPM results. The splenic RPM results from this study  dem onstra te  tha t 
E2 *supplem entatIon in OVX rabbits stim ulates a  hyperplastic ch an g e  In splenic red  pulp
m acrophages. A s previously d iscussed , th e  m echanism  for E ^ s  stim ulatory effect on
RPM proliferation Is not known. In evaluating th e  p resen t resu lts, e s tro g en s apparently  
play a  role In maintaining a  normal population of RPM in th e  rabbit since  RPM g rad es  
for th e  OVX non-E2 * supplem ented  g roups w ere, for the  m ost part, significantly lower
than the Intact and E2*supplem ented groups. As noted earlier, Fluhm ann (1928;
1932) observed  d ec reased  m acrophage num bers In th e  rabbit endom etrium  after 
ovariectom y. Similar ovariectom y-related m acrophage effects have  a lso  b een  reported 
In the  guinea pig (Ntchol, 1932; 1935) and  m ouse  (Nichol a n d  V ernon-R oberts,
1965). U eberm uth (1933) dem onstrated  d ec reased  sto rage  ability of m acrophages 
from postm enopausal hum an fem ales and early work by Antonlnl ef a/. (1960) linked 
decreased  postm enopausal m acrophage activity to an  increased Incidence of atheroscle­
rosis. T h ese  studies sug g est that m aintenance of physiological estrogen  levels m ay be 
important In conserving normal monocytic m acrophage system  function. While 
dec reased  num bers of RPM w ere a lso  observed In the  E2-dDfIclent groups in th is study,
the  m acrophages that w ere p resen t dem onstrated a  high hem osiderin content indicating 
th a t they w ere very actively involved in erythrophagocytosls. Therefore, It s e e m s  from 
th e se  findings that estrogen  m ay be  needed  to establish a  milieu for splenic RPM 
proliferation but m ay not be  n ecessa ry  for normal m acrophage function, a t lea s t a s  far 
a s  maintaining their capacity  for phagocytlzlng erythrocytes.
T he results from this study Indicate that E2 S stim ulatory effect Is sensitive to
the  actions of IN. The significant d e c rease  In splenic RPM g rade  for the  SOVX/IN 5.0 
group com pared to  the E2 -supplem ented group receiving the  sam e  do se  of IN m akes this
assum ption plausible. T hat the  RPM g rade  In th e  E2 *supplem ented group receiving the
IN do se  of 5.0 mg/kg bw/day In this study w as not significantly d e c re a sed  w hen 
com pared to  th e  OVX/E2  Control group while th o se  E2 -supplem ented groups In the  pilot
study receiving IN d o se s  of 1 0 . 0  and 13.0 mg/kg bw/day had d ec reased  red  pulp 
m acrophage populations, Indicates that the  IN effect Is dose  related.
Although the  m echanism  of Interaction of IN with RPM cannot be  elucidated from 
the  p resen t experim ent, several au thors have dem onstrated  that IN adm inistration can  
have an  effect on cell functions se p ara te  from Its action on blockade of prostaglandin 
production. R esearch  by Razln ef al. (1982) dem onstrated  d e c reased  binding of IgG- 
sensitized sh e ep  red blood cells (Fc receptor dependent) by m ouse peritoneal
m acrophages trea ted  In vitro with 1 pg/ml IN. They a lso  reported that IN treatm ent 
increased  p lasm a m em brane binding of cationlzed ferritin In th e se  cells. W hile the  
au thors of this study did not com pletely rule out prostaglandin involvement In their 
observations, they  did m ake a  c a se  for a  direct IN-induced reordering of m em brane 
su rface  ch arg es  being a t least partially responsible for their resu lts. Indom ethacin 
administration h as  a lso  been  shown to have a  direct selective Inhibitory effect on the  
re le a se  of lysosom al enzym es (D am as and  Bourdon, 1982; Finlay e ta / . ,  1975). O ther 
investigators have a lso  reported on IN's and o ther NSAIDs' direct effects on diverse 
m em brane-associated reactions such  a s  generation of superoxide by the NADPH system  
of the  neutrophil (Blemond ef al., 1986), phospholipase C activity In m ononuclear cells 
(Bomalaski ef al., 1986), and binding of G TPyS (a stab le  analog of GTP) to  neutrophil 
m em brane preparations (Abramson ef al., 1991). Indomethacin w as a lso  found
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effective In directly inhibiting hum an p late le t m em brane-derived and  rabbit polymor­
phonuclear leukocyte PLA2  (Je s se  and F ranson, 1979; Kaplan e f a/., 1978). In both
stud ies th e  PLA2  Inhibition w as do se  dependen t an d  occurred a t relatively low IN
concentrations.
Splenic hem osiderin results. Ovariectomy alone failed to  reduce the 
erythrophagocytlc capability of the  RPM since the  hem osiderin staining level for the OVX 
Control group w as not significantly different from th a t of the intact Control group. By 
contrast, the  m ean  sco re s  for the OVX/E2  Control and  OVX/E2 /IN 0.1 w ere significantly
lower than  that of the  intact Control group. The differences in hem osiderin levels m ay 
reflect an  adaptation by the  m acrophages to  changes in need  for phagocytic capacity, i.e., 
a  sm aller population of m acrophages ad justs to higher dem and for erythrocyte removal 
by increasing the  am ount phagocytlzed, w hereas a  larger m acrophage population 
proportionally Ingests a  sm aller quantity in response  to  the sam e  dem and. T he lack of 
significance betw een the  hem osiderin staining intensities of the  OVX/E2 /IN 5 .0  group
and  its respective control groups may indicate that th e  5.0 mg/kg bw/day IN d o se  is 
producing increased  d am ag e  to  the  erythrocytes resulting in g rea ter phagocytic activity 
on the  part of th e  RPM. The m arked d e c re a se  in hem atocrit In this group w hen com pared 
to  the  OVX/E2  Control and OVX/E2 /IN 0 .1  values also  su g g ests  that this IN d o se  results In
increased  erythrocyte dam age. A thorough search  of the literature failed to  uncover any  
research  that add ressed  the  issue of changes In phagocytic activity in response  to 
Increase o r d e c re a se  in m acrophage population density.
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H em atocrits.
Of Interest In th is Investigation w as the  significant d e c re a se  In th e  21-day  m ean 
hematocrit observed  in the  OVX Control and OVX/IN 5.0 groups and In all the  OVX groups 
receiving E2  supplem entation. This reduction In hem atocrit w as m ore pronounced In the
groups that received the  high IN dose. Both IN and  E2  have  been  linked to  the  Induction of
aplastic anem ia. Aplastic anem ia resulting from estrogen  adm inistration and  ch arac ­
terized by bone marrow hypoplasia h a s  been  reported In the  dog (Steinberg, 1970) and 
rat (Tanaka, 1965). Indom ethacin administration h as  been  linked to  aplastic  anem ia  In 
hum ans (Kornberg and Rachmllewitz, 1982). A single c a s e  of Indomethacin adm inis­
tration-related pu re  red  cell ap lasia  w as reported by Burghuber (1979). Evaluation of 
the  bone marrow sections In the p resen t study failed to  de tec t any significant differences 
In overall cellularlty o r num bers of erythrold precursors, Indicating tha t the  observed  
hematocrit c h a n g es  are not due to d e c reases  in red blood celt production. While the 
hematocrit ch an g es in th e  OVX Control group could be attributed to  a  response  to  surgical 
traum a, In the  o ther g roups a  likely explanation for the  d e c re a se  m ay be  related  to direct 
action of both IN and E2  on erythrocyte plasm a m em branes. Both of th ese  com pounds
have been  shown to produce changes In erythrocyte plasm a m em branes. Red blood cells 
from w om en w ho used  ethinyl estrad io l-based  birth control pills w ere found to  have 
reduced m em brane deform abilitles (Heilmann ef a/., 1981). Estrogenic com pounds 
w ere also found to  block the  In vitro uptake of m onosaccharides by hum an erythrocytes 
a s  well a s  decreasing  their m em brane Integrity (Ingermann, 1989). Addition of IN to 
w ashed  canine RBCs resulted In Increased m em brane stability a s  determ ined by 
Increased  res is tan ce  to  heat-induced hem olysis (Brown e f al., 1967). Indom ethacin- 
related RBC hem olysis h a s  been  reported in animal studies. Glgllo and  Bozzlni (1982)
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reported a  transien t d e c re a se  In hem atocrit along with Increased hem olysis In fem ale 
m ice receiving a  single 400 pg do se  of IN. Indomethacin h as  a lso  been  Implicated, even 
if anecdotally , In the autoim m une form of hemolytic anem ia In hum ans (Epner, 1094).
The splenic RPM play a  major role in th e  rem oval of ag ed  and  altered  erythro­
cy tes from th e  circulation (Auger and R oss, 1992) and have been  shown to be  able to 
de tec t RBCs with only slight p lasm a m em brane dam ag e  (Harris et al., 1957). Drug- 
Induced red cell m em brane dam age of a  minor nature would first be  detected  by splenic 
RPM that would rem ove th e se  cells from the  circulation. Continued dam age to  Increasing 
num bers of erythrocytes would further activate o ther splenic RPM and resu lt in an 
Increased cell population In the  splenic cords, producing the Increase In RPM grade 
observed In this study. Kay (1981) dem onstrated  an  IgG autoantlbody-blnding antigen 
on sen escen t and  dam aged mammalian erythrocytes and  som atic cells that s h e  feels is 
responsib le  for their rem oval from th e  circulation by m acrophages. O ther investigators 
have  show n In In vitro s tud ies that under certain pathologic conditions (e.g ., favlsm, P. 
falciparum Infection and  sickle cell anem ia) a  com plem ent recep to r (C R em edia ted  
m echanism  m ay be responsible for elimination of dam aged  erythrocytes (A rese e t  al,, 
1990). W hile a  CR-m edlated m echanism  for removal of dam aged erythrocytes cannot be 
ruled out, work by Buckley et al. (1987) h a s  dem onstrated  th a t over 75%  of splenic 
RPM stain positively for FCR (responsible for binding IgG coated  particles) while less
than  10% of th e s e  cells a re  positive for com plem ent factor CR3 recep to rs  (responsible 
for the  phagocytosis of com plem ent opsonized particles). In support of a  FcR -m ediated
m echanism  of splenic erythrocyte rem oval, Schroft et al. (1985) have show n that CR- 
m edlated  rem oval of RBCs occurs primarily by action of Kupffer cells in th e  liver.
Although an  im m une-m ediated c learance  m echanism  m ay b e  responsib le for the
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rem oval of m ost erythrocytes from circulation, a  non-lm m une m echanism  h a s  a lso  been  
described. C onner et at. (1994), In stud ies carried out In antibody-deficient SCID mice, 
observed th a t ag ed  red blood cells w ere rem oved from the circulation via a  m echanism  
that w as independent of antibody involvement. They reported that the erythrocyte 
removal ra te  by this non-lm mune m echanism  w as com parable to  the  c learance  rate  In 
Im m unocom petent BALB/c mice. T he possible Importance of th is non-lm m une rem oval 
pathw ay in normal anim als w as not ad d ressed , nor w as Us' role In the  rem oval of 
dam aged erythrocytes d iscussed . Sam brano e f at. (1994) have  a lso  described  non- 
antibody-dependent scavenger receptor m ediated phagocytosis of oxidatively dam aged  
erythrocytes by m ouse peritoneal m acrophages.
Conclusion
The resu lts of th e  in vtvo study Indicate th a t a  com plex Interaction Is occurring 
with coadm inistration of E2  and IN, There Is an  apparen t direct effect of both drugs on
the  splenic RPM, with E2  producing a  stimulatory effect and  IN directly acting to
partially inhibit the  effect of normal physiological levels of estrogen . Estradiol 
administration a p p ears  primarily to  m ediate an  Increase  In m acrophage population and  
not to  affect m acrophage erythrophagocytlc capacity. Sim ultaneously, both drugs m ay 
be  acting on  erythrocyte p lasm a m em branes to  ch an g e  their fragility characteristics, 
prompting Increased stimulation of the  splenic RPM to actively rem ove th e se  dam aged  
erythrocytes from the  circulation, thereby  lowering hem atocrit.
In vitro NZW Rabbit Ervthrocvte Fragility R esu lts 
T he results from th e  In vitro study Indicate that IN trea tm en t Increases both 
osm otic and  m echanical fragility of rabbit erythrocytes. T he osm otic fragility findings
differ from th e  therm al hem olysis resu lts  of Kalbhen e f al. (1970) who found tha t IN 
added  to w ashed  hum an erythrocytes stabilized the  m em branes against heat-induced 
hemolysis over a  range of concentrations (1 X 10*5 to  5  X 1 0 ^  M). T anaka e f a/.
(1973) have  a lso  reported tem peratu re  dependen t c h a n g es  In hem olysis characteristics 
of w ashed  rat erythrocytes In resp o n se  to  treatm ent with IN and  o ther NSAIDs. In their 
work they noted  that addition of th e se  com pounds inhibited hypotonic erythrocyte lysis a t  
0CC while promoting lysts a t 37°C. T em perature m ay b e  an  independen t variable In Its 
Influence on hemolysis w hen com pared to changes induced by osm otic s tre ss  since 
previous experim ents conducted under similar conditions a s  th e  p resen t work, except 
for Incubation of the sam ples a t 4°C, resulted In d ec reased  osm otic fragility of the  IN- 
trea ted  rabbit erythrocytes (data not shown).
T he erythrocyte fragility results of IN treatm ent observed  In this study su g g est 
that not only d o es  it have an  Influence on  the capacity of the  erythrocyte cell m em brane 
to  accom m odate to  osm otic s tress  but that it also h as  an  effect on the  ability of the  
cytoskeletal structure to  respond to  m echanical s tre ss . The effect of IN on eiythrocyte 
m echanical fragility properties ap p e ar  d o se  related  since  M izushtma e f a/. (1970) 
dem onstrated  that d o se s  of IN which w ere m ore than 10 tim es g rea ter than  th o se  used in 
my study protected  canine erythrocytes against m echanical s tre ss .
T he m echanism  or m echanism s of erythrocyte Interaction with IN and o ther 
NSAIDs have yet to be  conclusively determ ined although som e authors have reported that 
they  bind to  th e  outer erythrocyte m em brane In a  charge-related  m anner (S heetz  and  
Singer, 1974; Akl and Yam am oto, 1990). As a  c lass , NSAIDs a re  planar, anionic 
com pounds that partition Into lipid environm ents such  a s  the  celt m em brane bilayer. As 
d iscussed  above, severa l investigators have reported that this ability resu lts in their 
Involvement In inhibition of d iverse non-prostaglandin m ediated, m em brane-associa ted
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reactions (Blemond e f a/„ 1886; BomalaskI e f a/., 1986; A bram son e f a!., 1991), 
Another possible m echanism  for IN’s  effect on th e  erythrocyte m em brane m ay be 
through direct binding to  th e  band 3 anion transporter protein. This glycoprotein Is the 
m ajor transm em brane protein found In the  erythrocyte and  is essen tia l In th e  CO2
transport system  b ecau se  of its transm em brane exchange of C l' and  HC0 3 ~ (Passow ,
1986). Although anion transport ap p e a rs  the  m ajor function of the  band 3  protein it 
a lso  m ay be  involved In red  blood cell hypotonic hem olysis (Sato ef a/., 1993) and, 
becau se  of its connection to  spectrin via Its hinged cytosolic dom ain, a lso  ap p e a rs  to 
se rv e  a s  a  flexible m em brane anchor for the erythrocyte actin-spectrin  cytoskeleton 
(W ang, 1994). Of in terest in investigating the interaction of IN and  o ther NSAIDs with 
th e  erythrocyte Is the structure of th e  band 3 protein extracytoplasm ic w ater en trance  
channel. This channel Is lined by cationic am ino acids consisting primarily of lysine 
residues (WIddas and  Baker, 1993). Indirect ev idence of interaction of IN with lysine
h a s  been  provided by Mizushtma and  Sakai (1969) who dem onstrated  that the  lysine e -
am ino group binding com pound 2 ,4,6-trlnitrobenzene sulfonic acid  inhibited the  
m em brane stabilizing effect of IN aga in st heat-induced hem olysis of canine erythrocytes. 
Direct evidence of IN involvement in cellular m em brane anion exchange h as  been  shown 
by T o n n essen  ef al, (1989) who reported  that IN Inhibited transm em brane ex change  of 
C l ' and  HCO3 " In cultured Vero cells via a  non-prostaglandln-m edlated pathw ay.
Possible m em brane surface interaction of anionic NSAIDs is also  supported  by the  work 
of Akl and Yam am oto (1990), who used  flow mlcrocalorlmetry techn iques m easuring 
changes in enthalpy and entropy to  conclude that th e se  drugs bind to  erythrocyte surface 
m em brane proteins. O bservations from my research  th a t both osm otic and  m echanical 
fragility properties of th e  rabbit erythrocytes w ere affected by IN Indicate th a t the
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potential ex ists for IN’s  involvement with th e  band  3  protein.
T he addition of E2  to  rabbit erythrocytes produced c h a n g es  only In erythrocyte
MF characteristics. T he increased  MF observed m ay Indicate that, a t least under these  
experim ental conditions, E2 S effect is primarily through h indrance of th e  ability of the
cytoskeleton to  accom m odate to  changes In m echanical s tress. O ther researchers have 
reported c h an g es  In m echanical characteristics of erythrocytes obtained from w om en 
w ho used  oral contraceptives (Hellmann e f a l, 1981; Oskl e f  al. 1972). In both these  
stud ies the  investigators observed  that erythrocytes had a  d e c reased  ability to  deform, 
Indicating that they would be  m ore labile under conditions of m echanical s tre ss . While it 
Is tem pting to draw  correlations betw een th e  p resen t In vitro study and th e  stud ies of 
Hellmann and  Oskl, It should be  noted that other research  h a s  show n that estrogen  
adm inistration In vivo, either a s  estradiol o r a s  ethinyl estradiol, can  produce ch an g es 
In erythrocyte m em brane lipid com position that m ay alter their fragility ch a rac te ris ­
tics (Cho e f al., 1988; Le-Pettt-Thevenin ef a/., 1986; Fehily e f  a l,  1982). While no 
E2 -related effect on O F characteristics w as observed in the p resen t study, F lorence and
R ahm an in their in vitro resea rch  (1972) have dem onstrated  a n  E2 *protective effect of
erythrocytes against hypotonic hemolysis, In this study the au thors added  approxim ately 
35  jig of E2  In an  aqueous solution to  1 ml of w ashed  erythrocytes diluted by a  factor of a t
lea s t 1 0 0 0  to 1. In the  p resen t work a  low concentration of w ater-soluble E2  (500
pg/ml) w as added  to whole blood with erythrocyte PCVs ranging from 25% to 34%.
Given the results of the  current research  and that of Florence and  Rahm an, It would 
ap p ear that the  effect of E2  on erythrocyte OF Is dose  related.
Estradiol’s  m echanism  of erythrocyte interaction h a s  yet to  b e  fully e laborated . 
Brinkman etal .  (1972a) observed  that stero ids In general m ove rapidly a c ro ss
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erythrocyte m em branes apparently  by th e  m echanism  of sim ple diffusion; however, 
o ther resea rch  h a s  show n that binding will occur to  isolated m em brane proteins 
(Brlnkmann an d  Van d e r  Molen, 1972b; DeVenuto eta}., 1969). Brlnkmann and  Van 
dor Molen (1972b) evaluated  hum an erythrocyte m em brane protein binding of E2  and
other steroids In vitro and reported th a t binding w as nonsaturable and  d e c reased  with 
decreasing  polarity of the  steroid. T h ese  findings led them  to  conclude that steroid- 
m em brane protein interactions a re  nonspecific in nature . Given th e  similarity In 
structure  of stero ids to  the  cholesterol m olecule an d  their ability to  readily partition 
from aq u eo u s to  lipid environm ents, It w as felt th a t stero ids m ay Interact with 
m em branes through d irect intercalation Into th e  lipid bilayer (Wlllmer, 1961). 
S u b seq u en t in vitro research , however, h a s  shown th a t m any steroids, Including £ 2 1  n iay
reac t primarily with th e  hydrated polar head  g roups of m em brane phospholipids and 
orient parallel to  the water-lipld Interface (Cleary a n d  Zatz, 1977; Khaiat e f  al., 1975; 
F lorence and R ahm an, 1972). Work using calorimetric and  R am an spectroscopic  
techniques to  a s s e s s  the  Interaction of anesthetic  and  nonanesthetic  stero ids with 
dlpalmltoylphosphatldyl-choline liposom es su g g ests  that a  m em brane lipid-m ediated 
m echanism  Is Involved In the  action of th e se  su b s tan ces  (O’Leary e f al., 1964). R ecent 
work by Koefoed and Brahm (1994) h a s  shown that se x  horm ones added  to  hum an 
erythrocytes can  pass  through the cell m em brane and  bind to  cytoplasm ic com ponents 
but a re  predominantly found bound to m em brane-associated  structures. Given the 
different explanations for the  m echanism  of steroid and  erythrocyte interaction, it is 
difficult to  draw  definitive conclusions on E2 S role in th e  alteration of m em brane
fragility characteristics. If th e  m em brane lipid-mediated m echanism  of interaction is 
correct, then it would be  e a sy  to hypothesize that partitioning of E2  Into th e  m em brane
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bilayer m ay produce the  changes tn m echanical fragility that w e observed . M cPherson e f  
al. (1992) have reported that band 3 protein 's Integral dom ain undergoes rotational 
diffusion within the  erythrocyte m em brane under normal physiological conditions, 
h indrance of th is diffusion by Intercalation of E2 , or o ther steroid, Into th e  lipid bilayer
m ay com prom ise the ability of the  erythrocyte to  deform  In resp o n se  to m echanical 
s tre ss ,
The combination of IN plus E2  added  to rabbit erythrocytes failed to  produce a
significant change  In fragility characteristics when com pared to  IN addition alone. This 
apparen t lack of an  additive, synergistic o r dlmlnutional effect m ay indicate th a t the two 
drugs vary either in their deg ree  of m em brane Involvement or hav e  different loci or 
m echanism s of Interaction.
Conclusions.
W hen IN and E2  a lone w ere added  to  rabbit whole blood a t 39 .5 'C , both drugs
produced increases in m echanical fragility after 4  hours. Only IN had an  effect on 
osm otic fragility, producing a  d e c re a se  In the  ability of the erythrocytes to  respond to 
changes In osm otic s tress, The d eg ree  of Increased fragility w as g rea t enough to 
significantly Increase the  values of p 1 (50% hem olysis point) an d  p2  (hem olysis 
dispersion) but not sufficient to  m ake a  significant change  In PCV. C hanges In these  
facto rs a p p e a r  to be m ore critical Indicators of fragility d ifferences In rabbit erythro­
cy tes than Is the  PCV. Combination of the  two drugs failed to  produce resu lts that w ere 
significantly different from th e  m echanical fragility resu lts  for IN alone, indicating a  
lack of additive, synergistic or antagonistic Interaction of the two com pounds.
Chapter 5
SUMMARY CONOJUSIONS AND FUTURE PROSPECTS
Sum m ary Conclusions
In vivo NZW Rabbit Findings Sum m ary
• Ovariectomy reduced splenic red pulp m acrophage grade but did not d ec rease
ery throphagocytlc  activity.
• Estradiol supplem entation increased  splenic red pulp m acrophage g rad e  of
ovariectom tzed anim als.
• Indomethacin decreased  red pulp m acrophage grade In SOVX/IN 5.0  groups
v ersu s  the  OVX/E2 /IN 5 .0  group.
• Indom ethacin and estradiol administration d e c re a sed  rabbit hem atocrits
tn vitro NZW Rabbit Erythrocyte Fragility Findings Sum m ary
• Indom ethacin Increased  rabbit erythrocyte m echanical and  osm otic fragility.
• Estradiol Increased  rabbit erythrocyte m echanical fragility.
• No Interactive effect of Indom ethacin an d  estradiol on  rabbit erythrocyte
fragility characteristics w a s  observed .
T he resu lts of the  In vivo experim ent confirm th e  hypothesis of a  dose-rela ted  IN
inhibition of E2  stimulation of RPM activity. They a lso  dem onstra te  that th e  effect of E2
on th e  RPM is primarily that of Increasing the num ber of m acrophages rather than  
affecting their phagocytic capacities. Further, normal physiological levels of E2  protect
against the  high IN dose-induced d e c re a ses  In m ean hematocrit observed In the  OVX and 
OVX/E2  groups. The In Wfro resu lts  support th e  hypothesis th a t IN-lnduced erythrocyte
dam age contributes to the  d ec reases  observed in
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the  in vivo hem atocrits of th o se  OVX groups receiving the  high IN dose .
T he in vivo findings ag ree  with o ther re se a rc h e r 's  reports on  th e  stim ulatory 
effects of estradiol on cells of the m onocyte m acrophage system . The clinical significance 
of th is effect on splenic m acrophages h a s  never been  ad d ressed  and It Is possib le that If It 
d o es  occur In hum ans It m ay go undetected . Given the  cyclic nature of estrogen  
production under normal physiological conditions, changes In splenic m acrophage 
num bers In resp o n se  to  estrogen  level fluctuations m ay be transient. T he ex ac t nature of 
estrad io l's stim ulatory activity Is still a  m atter of conjecture although, given the  
literature findings, It is likely m ediated by receptor interaction. T he  exact location of 
th e  splenic red  pulp m acrophage estradiol binding site  still rem ains to be  determ ined. 
Indom ethac in 's  capacity to  partially reduce  the red  pulp m acrophage g rade  In the  
SOVX/IN 5.0 anim als in relation to  th e  OVX/Ez/IN 5 .0  anim als m ay be related  to  Its
ability to Interfere with E2 's  stim ulatory effect on  th e se  m acrophages ra ther than
blockade of erythrophagocytosls. This Is supported by the fact that there  w as no 
significant difference In m ean  hem osiderin g rade  betw een that of th e  SOVX/IN 5.0  group 
and Its trea tm en t regim en control group. W hether Indom ethacln 's Inhibitory actions on 
the  splenic m acrophages Involves the  sam e  m echanism  a s  d o es  estradiol's stimulatory 
activity Is not known.
T he effect of both indomethacin and estradiol on the in vivo hem atocrits Indicates 
that there  m ay b e  a  direct effect of th e se  drugs on  the  erythrocyte. The erythrocyte 
fragility resp o n se s  to indom ethacin observed  In th e  in vitro s tudy  have not b een  reported 
to  occur in vivo although one  group of researchers, evaluating the  effects of several 
NSAIDs on changes In m em brane structure using electron spin resonance  m easu rem en ts 
of hum an m ale and fem ale erythrocytes, did report th a t Ingestion of Indom ethacin (at a
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level of 50  mg) slightly changed  the  resonance  characteristics of erythrocytes from both 
se x e s  (Mazorow et a/., 1985). T h ese  authors a lso  Investigated the  In vitro effect of 
Indom ethacin (at 2  pg/ml) on w ashed  erythrocytes, noting no significant c h a n g e s  in 
m em brane structure. Com paring the/n vitro results obtained with the  IN d o se  used  by 
th e se  Investigators to  th e  results from th e  p resen t study using a  IN d o se  of 9 .6  pg/mt 
Indicates that a  d o se -resp o n se  relationship exists In IN's effect on erythrocyte 
m em brane properties.
Future P ro spec ts
Additional in vivo and in vitro (using either isolated m acrophages o r a  m acro­
phage cell line) resea rch  n eeds to be done  to clarify the  m echanism  of estradiol 
interaction with the  splenic red pulp m acrophages. This would consist of Immunohlsto- 
chem ical p rocedures to  determ ine w here on  the cell estradiol binds (i.e., cell m em brane 
versu s  nuclear binding) a s  well a s  its binding density. C hanges In cytokine ievels (e.g., 
IL-1, IL-3, etc.) should be  m onitored In the  In vivo and  in vitro s tu d ie s . Erythropoietin 
changes should a lso  be  m easured  in the  In vivo investigations. Further in vivo work 
should be done to confirm the  dose -response  relationship of indom ethacin 's effect on the 
estradiol-induced splenic red pulp m acrophage changes, a s  well a s  the  nature of the  
Interaction. This study would a lso  a s s e s s  the in vivo effect of indom ethacin and  estradiol 
on  th e  erythrocyte m em branes In term s of both fragility and  m em brane composition 
changes. T he effect of IN and Ez on  erythrocyte life-span should a lso  be a s se s s e d  to
determ ine w hether erythrocytes in anim als receiving one  or both of th ese  drugs have 
shorter life sp an s and  therefore, higher ra tes  of rem oval.
Two early In vitro, whole blood experim ents show ed that estradiol alone had an  
Influence on both m echanical and  osm otic erythrocyte fragility, a s  well a s  changing the
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Indom ethacln-induced fragility resp o n ses  of the  erythrocytes w hen adm inistered along 
with that drug, Another s e t  of In vitro experim ents using w ash ed  erythrocytes should be 
conducted to  ad d ress  the  possibility of an  estradiol d o se -resp o n se  effect on  both fragility 
param eters. Further In v/tro stud ies should a lso  be  done to determ ine th e  tim e course  of 
IN and E2  erythrocyte binding.
A second  a rea  of research would be to  evaluate the  effects of other NSAIDs in the 
sam e  research  paradigm s. T hese  studies would determ ine w hether the in vivo and  in 
vitro results observed using indomethacin are  com m on to th e  NSAIDs a s  a  c lass.
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Spteen Weights AN OVA Results
Source df Sum of Squares Mean Square F-Value P-Value
TREATMENT G... 9 9 .475 1.053 4.662 .000B
Residual 29 6.663 .230
Dependent: Spleen Wgt
Means Table
Effect: TREATMENT GROUP 
Dependent: Spleen Wgt
Count Mean Std. Dev. Std, Error
1 4 1.165 .158 .079
2 4 .977 .277 ,138
3 4 1.225 .279 .139
4 4 1.240 .441 .220
6 4 1.367 .535 .267
6 4 1.126 .361 .180
7 4 1.460 .222 ,111
8 4 2.472 .926 .464
9 4 2.357 .686 ,344
10 3 1.433 .266 .153
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Duncan N aw  Multiple Range  
Effect: TR EA TM EN T GR O U P  
Dependent: Spleen W g t 
Significance level: .05
Vs. D lff. Crit. dlff,
2 8 .1 5 0 .7 0 5
1 ,1 8 8 .7 4 1
3 ,2 4 8 .7 6 1
4 .2 6 3 .7 8 0
5 ,3 9 0 .7 9 3
1 0 .4 5 6 .6 0 3
7 .4 7 3 .8 1 0
8 1 .3 8 0 .6 1 6
6 1 .4 9 6 .8 2 1
6 1 .0 3 8 .7 0 6
3 .0 9 7 ,7 4 1
4 .1 1 2 .7 6 1
S .2 4 0 .7 8 0
1 0 .3 0 6 ,7 9 3
7 .3 2 2 .6 0 3
9 1 .2 3 0 .8 1 0
8 1 .3 4 5 .6 1 6
1 3 .0 8 0 .7 0 5
4 .0 7 6 .741
5 .2 0 2 .7 6 1
1 0 .2 6 8 .7 8 0
7 .2 8 6 .7 9 3
e 1 ,1 9 2 .8 0 3
6 1 .3 0 7 .8 1 0
3 4 .0 1 6 .70S
5 .1 4 2 .741
1 0 .2 0 6 .761
7 .2 2 5 .7 6 0
9 1 .1 3 2 .7 9 3
8 1 .2 4 7 .8 0 3
4 S .1 2 7 ,7 0 5
1 0 .1 9 3 .7 4 1
7 .2 1 0 .761
9 1 ,1 1 7 .7 8 0
8 1 .2 3 2 .7 9 3
5 1 0 .0 6 6 .7 0 5
7 .0 8 3 .741
9 .9 9 0 .781
8 1 .1 0 5 .7 8 0
1 0 7 .0 1 7 .7 0 5
9 ,9 2 4 .7 4 1
a 1 .0 3 9 ,761
7 9 .9 0 7 ,7 0 5
a 1 .0 2 2 ,741
0 8 .1 1 5 ,7 0 5
S  ■ Significantly different a t this level.
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S
s
s
s
s
s
s
s
s
8
S
8
8
S
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RPM • ANOVA Results
Source df Sum of Squares Mean Square F-Value P«Value
TREATMENT a . . 9 19.942 2 .216 4 .050 .0018
Residual 29 15.750 .543
Dependent: RE Hyperplasia
Mean* Table
Effect: TREATMENT GROUP 
Dependent: RE Hyperplasia
Count Mean Std. Dev. Std. Error
1 4 1.750 .500 .250
2 4 1.250 .500 .250
3 4 1.750 1.258 .829
4 4 2.750 .500 .250
6 4 2.500 .577 .289
6 4 2.000 .816 .408
7 4 3.250 .500 .250
8 4 3.000 .816 .408
9 4 3.500 .577 .289
10 3 3.000 1.000 .577
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Duncan N ew  M ultiple Range  
Effect: TR EA TM EN T GR O U P  
Dependent: RE Hyperplasia  
Significance level: .OS
Va. Dlff. Crlt. did.
2 1 .5 0 0 1 .0 0 4
3 .5 0 0 1 .1 3 9
6 .7 5 0 1 .1 7 1
0 1 .2 5 0 1 .1 9 9
4 1 .5 0 0 1 .2 1 9
1 0 1 .7 5 0 1 .2 3 4
B 1 .7 5 0 1 .2 4 5
7 2 .0 0 0 1 .2 6 5
0 2 .2 5 0 1 .2 0 2
1 3 0 .0 0 0 1 .0 8 4
0 .2 5 0 1 .1 3 9
6 .7 5 0 1 .1 7 1
4 1 .0 0 0 1 .1 9 9
1 0 1 ,2 6 0 1 .2 1 9
0 1 .2 6 0 1 .2 3 4
7 1 .6 0 0 1 .2 4 5
9 1 .7 6 0 1 .2 5 5
3 0 .2 6 0 1 .0 0 4
5 .7 6 0 1 .1 3 9
4 1 .0 0 0 1 .1 7 1
1 0 1 .2 6 0 1 .1 9 9
0 1 .2 6 0 1 .2 1 9
7 1 .5 0 0 1 .2 3 4
B 1 .7 6 0 1 .2 4 6
6 5 .6 0 0 1 .0 0 4
4 .7 5 0 1 .1 3 9
i o 1 .0 0 0 1 .1 7 1
0 1 .0 0 0 1 ,1 9 9
7 1 .2 5 0 1 .2 1 9
9 1 .5 0 0 1 .2 3 4
5 4 .2 5 0 1 .0 6 4
1 0 .6 0 0 1 ,1 3 9
0 .5 0 0 1 .1 7 1
7 ,7 5 0 1 .1 0 9
9 1 .0 0 0 1 .2 1 9
4 1 0 .2 6 0 1 .0 0 4
0 .2 6 0 1 .1 3 9
7 .6 0 0 1 .1 7 1
9 .7 5 0 1 .1 9 9
1 0 0 0 ,0 0 0 1 .0 5 4
7 .2 5 0 1 .1 3 9
9 .6 0 0 1 .1 7 1
0 7 .2 5 0 1 .0 0 4
9 .5 0 0 1 .1 3 9
7 9 .2 6 0 1 .0 0 4
S  -  Significantly different a t this level.
8
8
8
8
8
8
S
S
8
8
S
S
s
8
S
8
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Hemosiderin ANOVA Results
Source df Sum of Squares Mean Square F-Value P-Value
TREATMENTG... 8 26,827 2.981 2 .476 .0311
Residual 29 34,917 1.204
Dependent; HEMO. • IRON
Means Table
Effect: TREATMENT GROUP 
Dependent: HEMO. • IRON
Count Mean Std. Dev. Std. Error
1 4 2 .750 1.500 .750
2 4 2.250 .957 .479
3 4 3,250 ,500 ,250
4 4 2.750 ,957 .479
6 4 2.000 .616 .408
6 4 2.250 1.256 .629
7 4 1,250 .957 .479
6 4 .500 .577 .289
9 4 1.760 1.708 .854
10 3 3.333 1.155 .667
8 5
Duncan N aw  Muttlpla R an g *  
Eft act: TR EA TM EN T G R O U P  
D apandant: H EM O. •  IRON  
Significance lava): .09
Va. Olfl. Crlt. dlff.
Q 7 .7 8 0 1 .6 1 5
9 1 .2 8 0 1 .8 0 5
5 1 .5 0 0 1 .7 4 3
2 1 .7 5 0 1 ,7 8 6
e 1 .7 5 0 1 ,8 1 6
4 2 .2 5 0 1 ,8 3 6
1 2 .2 5 0 1 .8 6 4
3 2 .7 5 0 1 .8 6 6
1 0 2 ,8 3 3 1 .8 7 0
7 B .5 0 0 1 .6 1 6
6 .7 5 0 1 .6 9 6
2 1 .0 0 0 1 .7 4 3
8 1 .0 0 0 1 .7 8 6
4 1 .6 0 0 1 .8 1 5
1 1 .6 0 0 1 .6 3 6
3 2 ,0 0 0 1 .8 6 4
1 0 2 .0 8 3 1 .8 6 6
9 5 .2 6 0 1 ,6 1 6
2 .6 0 0 1 .8 9 5
8 .6 0 0 1 .7 4 3
4 1 .0 0 0 1 .7 8 5
1 1 .0 0 0 1 .6 1 5
3 1 .6 0 0 1 .8 3 8
1 0 1 .6 8 3 1 .8 5 4
5 2 .2 5 0 1 .6 1 5
8 .2 6 0 1 .6 9 5
4 .7 5 0 1 .7 4 3
1 .7 6 0 1 .7 8 5
3 1 .2 5 0 1 .8 1 6
1 0 1 .3 3 3 1 .8 3 8
2 6 0 .0 0 0 1 .6 1 5
4 .5 0 0 1 .8 9 5
1 .5 0 0 1 .7 4 3
3 1 .0 0 0 1 .7 8 5
1 0 1 .0 8 3 1 .8 1 5
e 4 .5 0 0 1 .8 1 6
1 .5 0 0 1 .8 9 5
3 1 .0 0 0 1 .7 4 3
1 0 1 ,0 8 3 1 .7 8 5
4 1 0 .0 0 0 1 .6 1 5
3 .5 0 0 1 .6 9 6
1 0 ,5 8 3 1 .7 4 3
1 3 .6 0 0 1 ,6 1 5
i o .5 8 3 1 ,6 9 5
3 i o .0 8 3 1 ,6 1 6
8  » Significantly dltfarant a t this laval.
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Paired t-Tests for Pretreatment and 21-day Hematocrits
OVX Control
Palrad t-Test X 1 : Pre Hemcrlt Y i  : Post Hemcrit
OF: Mean X - Y: Paired t value: Prob. (2-talll:
1.76 3 .6566 .0364
OVX/IN 0.1
Palrad t-Test X t  : Pra Hemcrlt Y 1 : Post Hemcrlt
DF: Mean X - Y: Paired t value: Prob. f2-tall):
1 ,375 1,2026 .3154
OVX/IN 5.0
Paired t-Test X i  : Pre Hemcrlt Y 1 : Post Hemcrlt
DF: Mean X - Y: Paired t value: Prob. (2-tall):
12 .625 2.4579 .091
SOVX Control
Paired t-Test X 1 : Pre Hemcrlt Y i  : Post Hemcrlt
DF: Mean X - Y: Paired 1 value: Prob. (2-tall):
1 .625 -1 .4945 .2319
SOVX/IN 0.1
Paired t-Test X •) : Pre Hemcrit Y 1 : Post Hemcrit
DF: Mean X - Y: Paired t value: Prob. (2-tall):
12 .625 1.4434 .2446
SOVX/IN 5.0
Palrad t-Test X 1 : Pra Hemcrit Y 1 : Poet Hemcrit
DF:____________ Mean X - Y: Paired t value: Prob. (2-tall):
| a  [ .875  | .7534 |.S 0 8
OVX/E2 Control
Paired t-Test X 1 : Pre Hemcrlt Y 1 : Poet Hemcrlt
DF:_____________Mean X - Y: Palrad t value: Prob. (2-tall):
[3  |2 .7 S  |2 .7 2 1 8  |.0 7 2 4
OVX/E2/IN 0.1
Palrad t-Test X 1 : Pra Hemcrit Y 1 : Post Hemcrit
DF: Mean X - Y: Paired t value: Prob. (2-tall):
|3 5.125 |4 .0 0 1 2 | .028
OVX/E2/IN 5 .0
Paired t-Test X 1 : Pra Hemcrit Y 1 : Post Hemcrit
DF:_____________Mean X - Y: Paired t value: Prob. (2-tall):
|3  [7 |3.2404 | .0478
Control
Paired t-Test X 1 : Pra Hemcrit Y 1 : Post Hemcrit
DF: Mean X - Y: Paired t value: Prob. (2-tail):
2 |.S  | .2774 |.8 0 7 5
Serum eetradlol level* • ANOVA Results
Source df Sum of Squares Mean Square F-Value P-Value
TREATMENT a . . 5 662851.313 132570.263 6.721 .0025
Residual 18 417132 .380 23174.021
Dependent: E2 Levels 1
Means Table
Effect: TREATMENT GROUP 
Dependent: E2 Levels 1
Count Mean Std. Dev. Std. Error
1 4 108,950 16.823 8.412
2 4 114.826 38.100 19.050
3 4 158.276 67.642 33.821
7 4 504.700 179.719 89.859
8 4 394.975 197.887 98.943
9 4 456.675 247.540 123.770
Duncan New Multiple Range 
Effect: TREATMENT GROUP 
Dependent: E2 Levels 1 
Significance level: .05
V... Dlff. Crit. dlff.
2 5,875 226.062
3 49.325 237.479
8 286.025 244.329 S
9 347.725 248.896 S
7 395.750 252.702 S
3 43.450 226.062
8 280.150 237.479 s
9 341.850 244.329 s
7 389.875 248.896 s
8 236.700 226,062 s
9 298,400 237.479 s
7 346.425 244.329 s
9 61.700 226.062
7 109.725 237.479
7 48,026 226.062
S = Significantly different at this level,
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PI 2-wty ANOVA • Treatment * Interval
Source dt Sum of Squares Mean Square F-Valua P-Valua
Treatment 3 .006 .002 4,120 .0104
Interval 1 .027 .027 53.140 .0001
Treatment * Int... 3 .007 .002 4.271 .0087
Residual 56 .029 .001
Dependent: PI
Least Squares Meant Table 
Effect Treatment * Interval 
Dependent P1
Control, Initial
Control, Final
Indomethacin, Final
Estradiol, Initial
Estradiol, Final 
I + E, Initial
Vs.
Indometliacln, Initial
Control, Final
Indomethacin, Initial
Indomethacin, Final
Estradiol, Initial
Estradiol, Final
I + E, Initial
I + E, Final
Indomethacin, Initial
Indomethacin, Final
Estradiol,
Estradiol, Final
I + E, Initial
I + E, Final
Indomethacin, Final
Estradiol, Initial
Estradiol, Final
I + E, Initial
I 4- E, Final
Estradiol, :
Estradiol, Final
I + E, Initial
I + E, Final
Estradiol, Final
I + E, Initial
I + E, Final
I + E. Initial 
I + E, Final 
U E , Final
Did. Std. Error
•,020
.001
-.060
.001
-.021
.001
-.060
.021
-.041
.021
-.001
.020
-.041
-.062
-7.500E-5
-.022
-.001
-.062
.062
.040
.061
-7.500E-5
-.022
-.001
-.062
.022
-.040
-.061
,011
.011
.011
.011
.011
.011
.011
.011
.011
.011
.011
.011
.011
.011
.011
.011
.011
.011
.011
.011
.011
.011
.011
.011
.011
.011
.011
,011
t-Test P-Value
•1.756
.114
•5.346
.107
•1.650
.054
•5.352
1.870
•3.590
1.863
-.094
1.610
•3.596
-5,460
-.007
-1.964
-.060
-5.466
5.453
3,496
5.400
-.007
•1.957
-.053
•5,460
1.904
-3.502
•5.406
.0645
.9097
.0001
.9150
.0696
.9570
.0001
.0667
.0007
.0677
.6254
.0756
.0007
.0001
.9947
.0545
.9526
.0001
.0001
.0009
.0001
.9947
.0553
.9579
.0001
.0620
.0009
.0001
5
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P2 2-Way ANOVA Result*
Source df Sum of Squares Mean Square F-Value P-Valua
Treatment 3 .001 3.543E-4 .643 .4762
Interval 1 .013 .013 30.025 .0001
Treatment * Int... 3 .001 3.810E-4 .006 .4439
Residual 56 .024 4.204E-4
Dependent: P2
Least Squares Means Table 
Effect: Treatment * Interval 
Dependent: P2
Vs. Diff. Std. Error t-Test P-Value
Control, Initial
Control, Final
Indomethacin, Initial
Indomethacin, Final
Estradiol, Initial
Estradiol, Final
I + E, Initial
Control, Final -.019 .010 -1.874 .0661
Indomsthadn, Initial -.002 .010 -.167 .8679
Indomethacin, Final -.037 .010 •3.646 .0006
Estradiol, Initial -.003 .010 -.263 .7932
Estradiol, Final -.023 .010 •2.225 .0301
1 4  E, Initial 2.625E-4 .010 .026 .9797
1 + E, Final -.037 .010 •3,619 .0006
Indomethacin, Initial .016 .010 1.707 .0934
Indomethacin, Final -.018 .010 -1.772 .0819
Estradiol, Initial .017 .010 1,611 .1129
Estradiol, Final -.004 .010 -.351 .7268
1 4 E, Initial .019 .010 1.900 .0626
1 4 E, Final -.016 .010 -1,745 .0B65
Indomethacin, Final -.036 .010 -3.479 .0010
Estradiol, Initial -.001 .010 -.096 ,9236
Estradiol, Final -.021 .010 -2.056 .0442
1 4 E, Initial .002 .010 .193 .6479
1 4 E, Final -.035 .010 -3.452 .0011
Estradiol, Initial .035 .010 3.382 .0013
Estradiol, Final .015 .010 1.420 .1610
1 4 E, Initial .038 .010 3.671 .0005
14  E, Final 2.750E-4 .010 .027 .9787
Estradiol, Final -.020 .010 •1.962 .0548
1 4 E, Initial .003 .010 .289 .7737
14 E, Final -.034 .010 •3.355 .0014
1 4 E, Initial .023 .010 2.251 .0283
1 4 E, Final -.014 .010 •1.394 .1689
1 4 E, Final -.037 .010 •3,644 .0006
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Mechanical Fragility * One-way ANOVA
Source_____________ df Sum of Squares Mean Square F-Value F-Value
Treatment 3 6B09.326 226B.776 13.927 .0001
Residual 92 14993.702 162.975
Dependent: Four
T u k e y > K ra m e r  
E l le c t:  T re a tm e n t
D ependen t: Four 
S ig n if ic a n c e  level: .05
Control
Estradiol
Indomethacin
Vs. Dlff. Crll. dlff.
Estradiol 10.653 9.676 S
Indomethacin 19,133 9.676 S
In + E2 19.158 9.676 S
Indomethacin 13.612 9.676 S
In + E2 13.638 9 .676 S
In + E2 .025 9.676
S ■ Significantly different at this level.
VITAE
PERSONAL DATA:
EDUCATION:
5 / 6 9
6 / 7 9
5 / 9 5
Born: July 11, 1946; N iagara Falls, New York 
Marital S ta tus: Single
B.S. Biology; Virginia Polytechnic Institute an d  S ta te  
University; B lacksburg, Virginia.
M.S. Pathoblology; University of C onnecticut; S torrs, 
Connecticut.
Ph.D. Biomedical S c iences (Pharmacology); J a m e s  H. Quillen 
College of Medicine, E ast T e n n e sse e  S ta te  University; 
Johnson  City, T ennessee .
EMPLOYMENT HISTORY: 
12/63 - p re se n t
10/81 - 3 /83  
5 /60  - 10/81
R esearch  Specialist; Departm ent of Pathology, Ja m e s  H. 
Quillen College of Medicine; East T en n essee  S tate  
University; Jo h n so n  City, T en n essee .
Project Controller and D ocum ent R esearcher; B loassay 
S ystem s Corporation; W oburn, M assachusetts.
Screening HIstopathologlst and  Technical M anager; 
B loassay System s Corporation; Old Saybrook, Connecticut 
and W oburn, M assachusetts.
TEACHING EXPERIENCE 
4/91 - p re se n t
6/90 - p re se n t
4 /76  - 6 /79
Lecturer in M edical Pharm acology; “Antlhyperllpldem lc 
D ru g s .”
Instructor for D epartm ent of Pathology residency  
p rogram .
Lecturer In P athobtobgy, various in troductory p a tho logy  
lectures
92
MILITARY SERVICE
6 /69  • 5 /75  United S ta te s  Navy; N uclear R eactor Electrical O perator
PUBLICATIONS:
Original Articles:
1 . Shurbaji, MS, Kuhajda, FP, Pasternack , GR, and Thurm ond, TS (1992).
Expression of O ncogenic Antigen 519 (OA-519) in p rosta te  cancer Is a  potential 
prognostic indicator. Am. J. Clin. Pathol. 97:689*91.
2 . Shurbajl, MS, Brooks, SK, and  Thurm ond, T S  (1993). Proliferating cell
nuclear an tigen  (PCNA) Immunoreactlvlty In cervical Intraepithellal neop lasia . 
Am. J. Clin. Pathol. 100:22*6.
3 . Shurbajl, MS, Kalbfletsch, JH , and  Thurm ond, TS (1994).
Imm unohlstochem lcal detection of p53 protein a s  a  prognostic indicator In 
p ro sta te  cancer. Hum. Pathol. 26:106*9
A bstracts:
1 . Zollars, PR, Thurmond, TS, Musil, G, and  C oogan, P S  (1965). Splenom egaly 
resulting from short-term  estrogen  adm inistration In rabbits. Fed. Proc. 
4 4 :8 4 5 .
2 .  Thurmond, TS, Kalin, GB, C oogan, PS, and  Chi, DS (1990). Further study of a  
m agnesium  deficiency-induced lym phosarcom a in the  rat. Proc. Soc. Exp. Biol. 
Med. 194:378,
3 .  Thurmond, TS, and Ferslew, KE (1991). Estradiol induced ch an g es  In rabbit 
sp leen  estrogen  receptors. J. Clin. Pharmacol. 31:291,
4 .  Shurbajl, MS, Thurmond, TS , Pasternack , GR, and  Kuhajda, FP (1991). 
Expression of haptoglobin related protein ep itopes by prosta te  carcinom a: A 
potential prognostic indicator. Lab. Invest. 64:52A.
5 . Shurbajl, MS, Thurmond, TS , P asternack , GR, Kuhajda, FP (1991). E xpression 
of haptoglobin related protein (Hpr) ep itopes by p rosta te  carcinom a Is a  
potential prognostic indicator. South. Med. J. 84(suppl. 2):90.
93
6 . Brooks, SK, Thurm ond, T S , and  Shurbajl, MS (1992). Proliferating cell nuclear 
an tigen  imm unoreactivlty In cervical Intraepithellal neop lasia . Am. J. Clin. 
Pathol. 98 :352-3 .
7 . Shurbajl, MS, Kalbflelsch, JH , Kuhajda, FP, Pasternack , GR, and  Thurmond, T S  
(1993). Expression of O ncogenic Antigen 519  (OA-519) In p rosta te  can ce r a s  a  
predictor of recurrence. Lab. Invest. 68:69A.
8 . Burja, IT, Thurm ond, TS, and  Shurbaji, MS (1993). Evaluation of prognostic
indicators in renal cell carcinom a. Am. J. Clin. Pathol. 100:317.
9 . R uidera, ER, Thurm ond, TS, and  Shurbaji, MS (1993). Prognostic significance
of flow cytom etry and OA519 In prosta te  cancer. Am. J. Clin. Pathol. 100:319.
1 0 . Shurbaji, MS, Kalbflelsch, JH , and  Thurm ond, TS (1994). Imm unohlstologlc 
detection of p53 protein and prognosis of prosta te  cancer. Mod. Pathol. 7:B3A.
1 1 . Ferslew , KE, Orcutt, RH, and  Thurmond, T S  (1995). In vitro effects of estradiol
(E2 ) and  indom ethacin (IN) on rabbit erythrocyte fragility (EF) charac te ris tics . 
Toxicologist 15:221.
1 2 . Orcutt, RH, Thurmond TS, and  Ferslew, KE (1995). M athem atical modeling of 
th e  osm otic fragility of rabbit red  blood cells. Toxicologist 15:222.
1 3 . Thurm ond, TS, Ferslew , KE, McCracken, MD, and C oogan, PS  (1995). 
Toxicopathology of indomethacin in the sp leen  of ovarlectomized, New Zealand 
W hite (NZW) rabbits. Toxicologist 15:227.
MANUSCRIPTS SUBMITTED FOR PUBLICATION:
1 . Thurmond, TS, Ferslew, KE, Orcutt, RH, an d  Coogan, PS . In vitro effects of 
estrad io l and Indom ethacin on rabbit erythrocyte fragility characteristics.
2 . Shurbaji, MS, Kalbflelsch, JH , and  Thurm ond, TS. Im m unohlstochem icai 
detection of a  fatty acid syn thase  (OA 519) a s  a  predictor of progression In 
p ro sta te  cancer.
3 . Thurmond, TS, Ferslew, KE, M cCracken, MD, and Coogan, PS . T he effect of 
indom ethacin administration on the  splenic changes Induced by estradiol 
supplem entation in ovarlectom ized New Zealand W hite rabbits.
94
